{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T22:00:12Z","timestamp":1789855212540,"version":"4.0.1"},"reference-count":477,"publisher":"The Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2,1]]},"DOI":"10.1210\/er.2015-1026","type":"journal-article","created":{"date-parts":[[2015,12,31]],"date-time":"2015-12-31T18:00:10Z","timestamp":1451584810000},"page":"62-110","source":"Crossref","is-referenced-by-count":145,"title":["Growth and the Growth Hormone-Insulin Like Growth Factor 1 Axis in Children With Chronic Inflammation: Current Evidence, Gaps in Knowledge, and Future Directions"],"prefix":"10.1210","volume":"37","author":[{"given":"S. C.","family":"Wong","sequence":"first","affiliation":[{"name":"Developmental Endocrinology Research Group (S.C.W., M.A.A., S.F.A.), University of Glasgow, Royal Hospital for Children, Glasgow G51 4TF, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Dobie","sequence":"additional","affiliation":[{"name":"Division of Developmental Biology (R.D., C.F.), Roslin Institute, University of Edinburgh, Midlothian EH25 9RG, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Altowati","sequence":"additional","affiliation":[{"name":"Developmental Endocrinology Research Group (S.C.W., M.A.A., S.F.A.), University of Glasgow, Royal Hospital for Children, Glasgow G51 4TF, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. A.","family":"Werther","sequence":"additional","affiliation":[{"name":"Hormone Research (G.A.W.), Murdoch Children's Research Institute, Melbourne, VIC 3052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Farquharson","sequence":"additional","affiliation":[{"name":"Division of Developmental Biology (R.D., C.F.), Roslin Institute, University of Edinburgh, Midlothian EH25 9RG, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. F.","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Developmental Endocrinology Research Group (S.C.W., M.A.A., S.F.A.), University of Glasgow, Royal Hospital for Children, Glasgow G51 4TF, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2015,12,31]]},"reference":[{"issue":"suppl 1","key":"2019041121300782800_B1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000229758","article-title":"Natural history of growth and body composition in juvenile idiopathic arthritis","volume":"72","author":"Bechtold","year":"2009","journal-title":"Horm Res"},{"key":"2019041121300782800_B2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000228581","article-title":"Growth retardation in early-onset inflammatory bowel disease: should we monitor and treat these patients differently?","volume":"27","author":"Griffiths","year":"2009","journal-title":"Dig Dis"},{"key":"2019041121300782800_B3","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/gut.34.7.939","article-title":"Growth and clinical course of children with Crohn's disease","volume":"34","author":"Griffiths","year":"1993","journal-title":"Gut"},{"key":"2019041121300782800_B4","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jpeds.2013.02.026","article-title":"Pubertal height velocity and associations with prepubertal and adult heights in cystic fibrosis","volume":"163","author":"Zhang","year":"2013","journal-title":"J Pediatr"},{"key":"2019041121300782800_B5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/03014460701824132","article-title":"Growth and nutritional status in children and adolescents with cystic fibrosis","volume":"35","author":"Um\u0142awska","year":"2008","journal-title":"Ann Hum Biol"},{"key":"2019041121300782800_B6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000329991","article-title":"Impact of inflammatory bowel disease on pubertal growth","volume":"76","author":"Mason","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"2019041121300782800_B7","first-page":"118","article-title":"Intermittent recombinant growth hormone treatment in short children born small for gestational age: four-year results of a randomized trial of two different treatment regimens","volume":"66","author":"Simon","year":"2006","journal-title":"Horm Res"},{"key":"2019041121300782800_B8","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/gut.52.3.454","article-title":"Adult height in patients with early onset of Crohn's disease","volume":"52","author":"Sawczenko","year":"2003","journal-title":"Gut"},{"key":"2019041121300782800_B9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1542\/peds.2005-2931","article-title":"Clinical features affecting final adult height in patients with pediatric-onset Crohn's disease","volume":"118","author":"Sawczenko","year":"2006","journal-title":"Pediatrics"},{"key":"2019041121300782800_B10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000369457","article-title":"A prospective longitudinal study of growth and pubertal progress in adolescents with inflammatory bowel disease","volume":"83","author":"Mason","year":"2015","journal-title":"Horm Res Paediatr"},{"key":"2019041121300782800_B11","first-page":"1011","article-title":"Cytokine actions in growth disorders associated with pediatric chronic inflammatory diseases (review)","volume":"18","author":"MacRae","year":"2006","journal-title":"Int J Mol Med"},{"key":"2019041121300782800_B12","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nrgastro.2014.102","article-title":"Growth problems in children with IBD","volume":"11","author":"Sanderson","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2019041121300782800_B13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/01.mpg.0000226374.18494.14","article-title":"The role of pro-inflammatory cytokines in inflammatory bowel disease growth retardation","volume":"43","author":"Wong","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019041121300782800_B14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1054-139X(02)00485-8","article-title":"Growth at puberty","volume":"31","author":"Rogol","year":"2002","journal-title":"J Adolesc Health"},{"key":"2019041121300782800_B15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-3476(85)80501-1","article-title":"Clinical longitudinal standards for height and height velocity for North American children","volume":"107","author":"Tanner","year":"1985","journal-title":"J Pediatr"},{"key":"2019041121300782800_B16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/03014467600001231","article-title":"The adolescent growth spurt of boys and girls of the Harpenden growth study","volume":"3","author":"Tanner","year":"1976","journal-title":"Ann Hum Biol"},{"key":"2019041121300782800_B17","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1515\/jpem.2011.216","article-title":"Accelerated carpal bone maturation in juvenile idiopathic arthritis: pitfall for bone age measurement","volume":"24","author":"Borzutzky","year":"2011","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2019041121300782800_B18","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/archdischild-2011-300771","article-title":"Growth in children receiving contemporary disease specific therapy for Crohn's disease","volume":"97","author":"Malik","year":"2012","journal-title":"Arch Dis Child"},{"key":"2019041121300782800_B19","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00431-007-0484-1","article-title":"Osteoporosis in juvenile idiopathic arthritis\u2013a practical approach to diagnosis and therapy","volume":"166","author":"Roth","year":"2007","journal-title":"Eur J Pediatr"},{"key":"2019041121300782800_B20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/MPG.0b013e31821988a3","article-title":"Skeletal health of children and adolescents with inflammatory bowel disease","volume":"53","author":"Pappa","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019041121300782800_B21","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/rheumatology\/keu489","article-title":"Growth in children and adolescents with juvenile idiopathic arthritis over 2 years of treatment with etanercept: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study","volume":"54","author":"Kearsley-Fleet","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"2019041121300782800_B22","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/rheumatology\/keu489","article-title":"Growth in children and adolescents with juvenile idiopathic arthritis over 2 years of treatment with etanercept: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study","volume":"54","author":"Kearsley-Fleet","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"2019041121300782800_B23","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/ppul.21127","article-title":"Growth in children with cystic fibrosis-related diabetes","volume":"44","author":"Cheung","year":"2009","journal-title":"Pediatr Pulmonol"},{"key":"2019041121300782800_B24","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/adc.2010.204636","article-title":"Once daily insulin detemir in cystic fibrosis with insulin deficiency","volume":"97","author":"Hameed","year":"2012","journal-title":"Arch Dis Child"},{"key":"2019041121300782800_B25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000271912","article-title":"Cystic fibrosis-related diabetes in childhood","volume":"73","author":"O'Riordan","year":"2010","journal-title":"Horm Res Paediatr"},{"key":"2019041121300782800_B26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00431-013-2174-5","article-title":"Pathological fractures in paediatric patients with inflammatory bowel disease","volume":"173","author":"Wong","year":"2014","journal-title":"Eur J Pediatr"},{"key":"2019041121300782800_B27","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/01.med.0000436191.87727.ec","article-title":"Cystic fibrosis-related bone disease: insights into a growing problem","volume":"20","author":"Stalvey","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2019041121300782800_B28","doi-asserted-by":"crossref","first-page":"569417","DOI":"10.4061\/2011\/569417","article-title":"Secondary osteoporosis in patients with juvenile idiopathic arthritis","volume":"2011","author":"Brabnikova Maresova","year":"2011","journal-title":"J Osteoporos"},{"key":"2019041121300782800_B29","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.pcl.2011.07.006","article-title":"Growth hormone: the expansion of available products and indications","volume":"58","author":"Franklin","year":"2011","journal-title":"Pediatr Clin North Am"},{"key":"2019041121300782800_B30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2265.2011.03937.x","article-title":"Growth hormone treatment for Turner syndrome in Australia reveals that younger age and increased dose interact to improve response","volume":"74","author":"Hughes","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121300782800_B31","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/EJE-12-1032","article-title":"Adult height in girls with Turner syndrome treated from before 6 years of age with a fixed per kilogram GH dose","volume":"169","author":"Wasniewska","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"2019041121300782800_B32","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1530\/eje.0.1510567","article-title":"Early treatment with GH alone in Turner syndrome: prepubertal catch-up growth and waning effect","volume":"151","author":"Wasniewska","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"2019041121300782800_B33","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1210\/jc.2012-1987","article-title":"Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial","volume":"97","author":"Lem","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121300782800_B34","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000327373","article-title":"Short children with low birth weight born either small for gestational age or average for gestational age show similar growth response and changes in insulin-like growth factor-1 to growth hormone treatment during the first prepubertal year","volume":"76","author":"Ranke","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"2019041121300782800_B35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2265.2011.04230.x","article-title":"Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature","volume":"77","author":"Hughes","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121300782800_B36","doi-asserted-by":"crossref","first-page":"E1383","DOI":"10.1210\/jc.2013-1222","article-title":"GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial","volume":"98","author":"Blum","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121300782800_B37","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1210\/jc.2013-2012","article-title":"Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects","volume":"98","author":"Bakker","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121300782800_B38","first-page":"CD003264","article-title":"Growth hormone for children with chronic kidney disease","volume":"2","author":"Hodson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2019041121300782800_B39","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1210\/jc.2007-0544","article-title":"Growth hormone increases final height in patients with juvenile idiopathic arthritis: data from a randomized controlled study","volume":"92","author":"Bechtold","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121300782800_B40","doi-asserted-by":"crossref","first-page":"T1","DOI":"10.1530\/JME-14-0022","article-title":"Recent research on the growth plate: recent insights into the regulation of the growth plate","volume":"53","author":"Lui","year":"2014","journal-title":"J Mol Endocrinol"},{"key":"2019041121300782800_B41","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1210\/jc.2007-0526","article-title":"The somatomedin hypothesis 2007: 50 years later","volume":"92","author":"Kaplan","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121300782800_B42","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1210\/er.2015-1048","article-title":"Regulation of long bone growth in vertebrates; it is time to catch up","volume":"36","author":"Rosell\u00f3-D\u00edez","year":"2015","journal-title":"Endocr Rev"},{"key":"2019041121300782800_B43","doi-asserted-by":"crossref","first-page":"7932","DOI":"10.1073\/pnas.83.20.7932","article-title":"Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin","volume":"83","author":"Schlechter","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121300782800_B44","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0022-2143(97)90076-7","article-title":"Stimulation of sulfate and thymidine incorporation into hypophysectomized rat cartilage by growth hormone and insulin-like growth factor-I in vitro: the somatomedin hypothesis revisited","volume":"129","author":"Salmon","year":"1997","journal-title":"J Lab Clin Med"},{"key":"2019041121300782800_B45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/dbio.2000.9975","article-title":"Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth","volume":"229","author":"Lupu","year":"2001","journal-title":"Dev Biol"},{"key":"2019041121300782800_B46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1677\/joe.0.1800247","article-title":"Evidence supporting dual, IGF-I-independent and IGF-I-dependent, roles for GH in promoting longitudinal bone growth","volume":"180","author":"Wang","year":"2004","journal-title":"J Endocrinol"},{"key":"2019041121300782800_B47","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1172\/JCI10753","article-title":"Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5","volume":"106","author":"Sims","year":"2000","journal-title":"J Clin Invest"},{"key":"2019041121300782800_B48","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1210\/en.2002-220948","article-title":"Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms","volume":"144","author":"Mohan","year":"2003","journal-title":"Endocrinology"},{"key":"2019041121300782800_B49","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1210\/en.2006-1264","article-title":"Insulin-like growth factor-I and fibroblast growth factor, but not growth hormone, affect growth plate chondrocyte proliferation","volume":"148","author":"Hutchison","year":"2007","journal-title":"Endocrinology"},{"key":"2019041121300782800_B50","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1210\/en.2006-0196","article-title":"Insulin-like growth factor-I is essential for embryonic bone development","volume":"147","author":"Wang","year":"2006","journal-title":"Endocrinology"},{"key":"2019041121300782800_B51","article-title":"Regulation of skeletal growth and mineral acquisition by the GH\/IGF-1 axis: lessons from mouse models [published online September 28, 2015]","author":"Yakar","journal-title":"Growth Horm IGF Res"},{"key":"2019041121300782800_B52","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.1073\/pnas.96.13.7324","article-title":"Normal growth and development in the absence of hepatic insulin-like growth factor I","volume":"96","author":"Yakar","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121300782800_B53","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1096\/fj.08-118976","article-title":"Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism","volume":"23","author":"Yakar","year":"2009","journal-title":"FASEB J"},{"key":"2019041121300782800_B54","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1152\/physiolgenomics.00022.2007","article-title":"Disruption of insulin-like growth factor-I expression in type II\u03b1I collagen-expressing cells reduces bone length and width in mice","volume":"30","author":"Govoni","year":"2007","journal-title":"Physiol Genomics"},{"key":"2019041121300782800_B55","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1210\/en.2009-0272","article-title":"Elevated levels of insulin-like growth factor (IGF)-I in serum rescue the severe growth retardation of IGF-I null mice","volume":"150","author":"Wu","year":"2009","journal-title":"Endocrinology"},{"key":"2019041121300782800_B56","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1210\/en.2014-1983","article-title":"Insulin-like growth factor-independent effects of growth hormone on growth plate chondrogenesis and longitudinal bone growth","volume":"156","author":"Wu","year":"2015","journal-title":"Endocrinology"},{"key":"2019041121300782800_B57","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1210\/en.2014-1160","article-title":"Combined treatment with GH and IGF-I: additive effect on cortical bone mass but not on linear bone growth in female rats","volume":"155","author":"Sundstr\u00f6m","year":"2014","journal-title":"Endocrinology"},{"key":"2019041121300782800_B58","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1242\/dmm.006775","article-title":"Unbound (bioavailable) IGF1 enhances somatic growth","volume":"4","author":"Elis","year":"2011","journal-title":"Dis Model Mech"},{"key":"2019041121300782800_B59","first-page":"157","article-title":"Endocrine regulation of the growth plate","volume":"64","author":"Nilsson","year":"2005","journal-title":"Horm Res"},{"key":"2019041121300782800_B60","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00003086-197105000-00029","article-title":"Cell population kinetics of bone growth: the first ten years of autoradiographic studies with tritiated thymidine","volume":"76","author":"Kember","year":"1971","journal-title":"Clin Orthop Relat Res"},{"key":"2019041121300782800_B61","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1210\/endo.143.5.8776","article-title":"The role of the resting zone in growth plate chondrogenesis","volume":"143","author":"Abad","year":"2002","journal-title":"Endocrinology"},{"key":"2019041121300782800_B62","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/229428a0","article-title":"Control of bone growth in rats","volume":"229","author":"Kember","year":"1971","journal-title":"Nature"},{"key":"2019041121300782800_B63","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/jemt.1070280606","article-title":"Mechanism of longitudinal bone growth and its regulation by growth plate chondrocytes","volume":"28","author":"Hunziker","year":"1994","journal-title":"Microsc Res Tech"},{"key":"2019041121300782800_B64","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/9467","article-title":"VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation","volume":"5","author":"Gerber","year":"1999","journal-title":"Nat Med"},{"key":"2019041121300782800_B65","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/jor.1100070505","article-title":"Cellular turnover at the chondro-osseous junction of growth plate cartilage: analysis by serial sections at the light microscopical level","volume":"7","author":"Farnum","year":"1989","journal-title":"J Orthop Res"},{"key":"2019041121300782800_B66","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1172\/JCI117058","article-title":"Differential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vivo","volume":"93","author":"Hunziker","year":"1994","journal-title":"J Clin Invest"},{"key":"2019041121300782800_B67","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1210\/endo.141.8.7624","article-title":"Effect of growth hormone and insulin-like growth factor I (IGF-I) on the expression of IGF-I messenger ribonucleic acid and peptide in rat tibial growth plate and articular chondrocytes in vivo","volume":"141","author":"Reinecke","year":"2000","journal-title":"Endocrinology"},{"key":"2019041121300782800_B68","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00467-012-2271-0","article-title":"Inflammation and linear bone growth: the inhibitory role of SOCS2 on GH\/IGF-1 signaling","volume":"28","author":"Farquharson","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"2019041121300782800_B69","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/jcp.21593","article-title":"Increased bone mass, altered trabecular architecture and modified growth plate organization in the growing skeleton of SOCS2 deficient mice","volume":"218","author":"Macrae","year":"2009","journal-title":"J Cell Physiol"},{"key":"2019041121300782800_B70","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1002\/jcp.25006","article-title":"Increased linear bone growth by GH in the absence of SOCS2 is independent of IGF-1","volume":"230","author":"Dobie","year":"2015","journal-title":"J Cell Physiol"},{"key":"2019041121300782800_B71","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1677\/joe.1.06609","article-title":"The restricted potential for recovery of growth plate chondrogenesis and longitudinal bone growth following exposure to pro-inflammatory cytokines","volume":"189","author":"MacRae","year":"2006","journal-title":"J Endocrinol"},{"key":"2019041121300782800_B72","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0736-0266(00)00078-4","article-title":"Induction of apoptosis in chondrocytes by tumor necrosis factor-\u03b1","volume":"19","author":"Aizawa","year":"2001","journal-title":"J Orthop Res"},{"key":"2019041121300782800_B73","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1359\/JBMR.040805","article-title":"Interleukin-1\u03b2 and TNF-\u03b1 act in synergy to inhibit longitudinal growth in fetal rat metatarsal bones","volume":"19","author":"M\u00e5rtensson","year":"2004","journal-title":"J Bone Miner Res"},{"key":"2019041121300782800_B74","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/pr.2014.84","article-title":"Inhibition of IGF-I-related intracellular signaling pathways by proinflammatory cytokines in growth plate chondrocytes","volume":"76","author":"Choukair","year":"2014","journal-title":"Pediatr Res"},{"key":"2019041121300782800_B75","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1172\/JCI113823","article-title":"Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes","volume":"82","author":"Goldring","year":"1988","journal-title":"J Clin Invest"},{"key":"2019041121300782800_B76","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1006\/cyto.1999.0577","article-title":"Tumour necrosis factor-\u03b1 up-regulates the expression of BMP-4 mRNA but inhibits chondrogenesis in mouse clonal chondrogenic EC cells, ATDC5","volume":"12","author":"Horiguchi","year":"2000","journal-title":"Cytokine"},{"key":"2019041121300782800_B77","first-page":"1187","article-title":"Effect of interleukin-6 on the chondrocytes in the cartilage endplate of rabbits in vitro [in Chinese]","volume":"27","author":"Ye","year":"2007","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"2019041121300782800_B78","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/jbmr.5650110811","article-title":"Evidence that interleukin-1, but not interleukin-6, affects costochondral chondrocyte proliferation, differentiation, and matrix synthesis through an autocrine pathway","volume":"11","author":"Horan","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2019041121300782800_B79","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cyto.2009.05.002","article-title":"Interleukin-6 inhibits early differentiation of ATDC5 chondrogenic progenitor cells","volume":"47","author":"Nakajima","year":"2009","journal-title":"Cytokine"},{"key":"2019041121300782800_B80","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1074\/jbc.M110773200","article-title":"JAK\/STAT but not ERK1\/ERK2 pathway mediates interleukin (IL)-6\/soluble IL-6R down-regulation of type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. Association with a down-regulation of Sox9 expression","volume":"278","author":"Legendre","year":"2003","journal-title":"J Biol Chem"},{"key":"2019041121300782800_B81","article-title":"Interleukin-6 acts locally on the growth plate to impair bone growth [published online July 17, 2013]","author":"Fernandez-Vojvodich","journal-title":"Ann Rheum Dis"},{"key":"2019041121300782800_B82","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000330726","article-title":"The biologics anakinra and etanercept prevent cytokine-induced growth retardation in cultured fetal rat metatarsal bones","volume":"76","author":"Fernandez-Vojvodich","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"2019041121300782800_B83","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000337569","article-title":"Pro-inflammatory cytokines produced by growth plate chondrocytes may act locally to modulate longitudinal bone growth","volume":"77","author":"Fernandez-Vojvodich","year":"2012","journal-title":"Horm Res Paediatr"},{"key":"2019041121300782800_B84","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1152\/ajpendo.00335.2012","article-title":"IL-1RI participates in normal growth plate development and bone modeling","volume":"305","author":"Simsa-Maziel","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121300782800_B85","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/adc.88.11.995","article-title":"Presenting features of inflammatory bowel disease in Great Britain and Ireland","volume":"88","author":"Sawczenko","year":"2003","journal-title":"Arch Dis Child"},{"key":"2019041121300782800_B86","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1365-2265.2007.02908.x","article-title":"Cytokine profiling and in vitro studies of murine bone growth using biological fluids from children with juvenile idiopathic arthritis","volume":"67","author":"MacRae","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121300782800_B87","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.4049\/jimmunol.172.12.7713","article-title":"IL-1\u03b2 impairs insulin-like growth factor I-induced differentiation and downstream activation signals of the insulin-like growth factor I receptor in myoblasts","volume":"172","author":"Broussard","year":"2004","journal-title":"J Immunol"},{"key":"2019041121300782800_B88","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/jnr.20081","article-title":"Rescue of TNF\u03b1-inhibited neuronal cells by IGF-1 involves Akt and c-Jun N-terminal kinases","volume":"76","author":"Kenchappa","year":"2004","journal-title":"J Neurosci Res"},{"key":"2019041121300782800_B89","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/ard.53.2.128","article-title":"Effects of interleukin-1 \u03b2 on insulin-like growth factor-I autocrine\/paracrine axis in cultured rat articular chondrocytes","volume":"53","author":"Matsumoto","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"2019041121300782800_B90","first-page":"4746","article-title":"Proinflammatory cytokines block growth of breast cancer cells by impairing signals from a growth factor receptor","volume":"62","author":"Shen","year":"2002","journal-title":"Cancer Res"},{"key":"2019041121300782800_B91","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1210\/en.2003-1749","article-title":"Proinflammatory cytokine impairment of insulin-like growth factor I-induced protein synthesis in skeletal muscle myoblasts requires ceramide","volume":"145","author":"Strle","year":"2004","journal-title":"Endocrinology"},{"key":"2019041121300782800_B92","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ghir.2007.05.002","article-title":"IGF-I signalling in bone growth: inhibitory actions of dexamethasone and IL-1\u03b2","volume":"17","author":"Macrae","year":"2007","journal-title":"Growth Horm Igf Res"},{"key":"2019041121300782800_B93","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.4049\/jimmunol.166.5.3491","article-title":"Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase\/STAT signaling pathway","volume":"166","author":"Li","year":"2001","journal-title":"J Immunol"},{"key":"2019041121300782800_B94","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1074\/jbc.275.6.3841","article-title":"Role of the suppressor of cytokine signaling-3 in mediating the inhibitory effects of interleukin-1\u03b2 on the growth hormone-dependent transcription of the acid-labile subunit gene in liver cells","volume":"275","author":"Boisclair","year":"2000","journal-title":"J Biol Chem"},{"key":"2019041121300782800_B95","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1210\/en.2006-0129","article-title":"Interleukin-1\u03b2 attenuates renin gene expression via a mitogen-activated protein kinase kinase-extracellular signal-regulated kinase and signal transducer and activator of transcription 3-dependent mechanism in As4.1 cells","volume":"147","author":"Liu","year":"2006","journal-title":"Endocrinology"},{"key":"2019041121300782800_B96","doi-asserted-by":"crossref","first-page":"34733","DOI":"10.1074\/jbc.M403886200","article-title":"Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling","volume":"279","author":"Shi","year":"2004","journal-title":"J Biol Chem"},{"key":"2019041121300782800_B97","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ki.2013.196","article-title":"Epiphyseal growth plate growth hormone receptor signaling is decreased in chronic kidney disease-related growth retardation","volume":"84","author":"Troib","year":"2013","journal-title":"Kidney Int"},{"key":"2019041121300782800_B98","doi-asserted-by":"crossref","first-page":"G646","DOI":"10.1152\/ajpgi.00178.2002","article-title":"Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3","volume":"284","author":"Denson","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2019041121300782800_B99","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/cbf.1551","article-title":"Inflammatory cytokines and the GH\/IGF-I axis: novel actions on bone growth","volume":"27","author":"Pass","year":"2009","journal-title":"Cell Biochem Funct"},{"key":"2019041121300782800_B100","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/jbmr.1544","article-title":"SOCS2 is the critical regulator of GH action in murine growth plate chondrogenesis","volume":"27","author":"Pass","year":"2012","journal-title":"J Bone Miner Res"},{"key":"2019041121300782800_B101","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1677\/JOE-10-0045","article-title":"The effect of GH and IGF1 on linear growth and skeletal development and their modulation by SOCS proteins","volume":"206","author":"Ahmed","year":"2010","journal-title":"J Endocrinol"},{"key":"2019041121300782800_B102","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0092-8674(87)90752-5","article-title":"Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene","volume":"49","author":"Jantzen","year":"1987","journal-title":"Cell"},{"key":"2019041121300782800_B103","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1210\/edrv-17-6-587","article-title":"Interaction of steroid hormone receptors with the transcription initiation complex","volume":"17","author":"Beato","year":"1996","journal-title":"Endocr Rev"},{"key":"2019041121300782800_B104","first-page":"435","article-title":"Molecular control of immune\/inflammatory responses: interactions between nuclear factor-\u03ba B and steroid receptor-signaling pathways","volume":"20","author":"McKay","year":"1999","journal-title":"Endocr Rev"},{"key":"2019041121300782800_B105","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1210\/en.2004-1152","article-title":"Dexamethasone induces apoptosis in proliferative chondrocytes through activation of caspases and suppression of the Akt-phosphatidylinositol 3\u2032-kinase signaling pathway","volume":"146","author":"Chrysis","year":"2005","journal-title":"Endocrinology"},{"key":"2019041121300782800_B106","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/endo-125-1-165","article-title":"Dexamethasone inhibits growth hormone induction of insulin-like growth factor-I (IGF-I) messenger ribonucleic acid (mRNA) in hypophysectomized rats and reduces IGF-I mRNA abundance in the intact rat","volume":"125","author":"Luo","year":"1989","journal-title":"Endocrinology"},{"key":"2019041121300782800_B107","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s004670000344","article-title":"Suppression of growth plate chondrocyte proliferation by corticosteroids","volume":"14","author":"Klaus","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"2019041121300782800_B108","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/s-2007-1003302","article-title":"Comparative effect of clonidine and growth hormone (GH)-releasing hormone on GH secretion in adult patients on chronic glucocorticoid therapy","volume":"24","author":"Giustina","year":"1992","journal-title":"Horm Metab Res"},{"key":"2019041121300782800_B109","first-page":"717","article-title":"Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human","volume":"19","author":"Giustina","year":"1998","journal-title":"Endocr Rev"},{"key":"2019041121300782800_B110","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/jcb.20192","article-title":"Dexamethasone inhibits insulin-induced chondrogenesis of ATDC5 cells by preventing PI3K-Akt signaling and DNA binding of Runx2","volume":"93","author":"Fujita","year":"2004","journal-title":"J Cell Biochem"},{"key":"2019041121300782800_B111","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1210\/en.2003-1435","article-title":"Insulin-like growth factor-I augments chondrocyte hypertrophy and reverses glucocorticoid-mediated growth retardation in fetal mice metatarsal cultures","volume":"145","author":"Mushtaq","year":"2004","journal-title":"Endocrinology"},{"key":"2019041121300782800_B112","first-page":"E489","article-title":"Dexamethasone acts locally to inhibit longitudinal bone growth in rabbits","volume":"263","author":"Baron","year":"1992","journal-title":"Am J Physiol"},{"key":"2019041121300782800_B113","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/07435809909066134","article-title":"Cytochemical demonstration of the glucocorticoid receptor in skeletal cells of the rat","volume":"25","author":"Silvestrini","year":"1999","journal-title":"Endocr Res"},{"key":"2019041121300782800_B114","first-page":"883","article-title":"The localization of the functional glucocorticoid receptor \u03b1 in human bone","volume":"85","author":"Abu","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121300782800_B115","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.mce.2006.11.006","article-title":"The growth plate sparing effects of the selective glucocorticoid receptor modulator, AL-438","volume":"264","author":"Owen","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121300782800_B116","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1677\/joe.0.1760331","article-title":"Growth retardation induced by dexamethasone is associated with increased apoptosis of the growth plate chondrocytes","volume":"176","author":"Chrysis","year":"2003","journal-title":"J Endocrinol"},{"key":"2019041121300782800_B117","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3892\/mmr.2014.1915","article-title":"Dexamethasone reduces ATDC5 chondrocyte cell viability by inducing autophagy","volume":"9","author":"Zhao","year":"2014","journal-title":"Mol Med Rep"},{"key":"2019041121300782800_B118","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S8756-3282(02)00855-4","article-title":"Dexamethasone inhibits and thyroid hormone promotes differentiation of mouse chondrogenic ATDC5 cells","volume":"31","author":"Siebler","year":"2002","journal-title":"Bone"},{"key":"2019041121300782800_B119","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1677\/joe.0.1750705","article-title":"Glucocorticoid effects on chondrogenesis, differentiation and apoptosis in the murine ATDC5 chondrocyte cell line","volume":"175","author":"Mushtaq","year":"2002","journal-title":"J Endocrinol"},{"key":"2019041121300782800_B120","doi-asserted-by":"crossref","first-page":"33249","DOI":"10.1074\/jbc.M010127200","article-title":"p21cip-1\/SDI-1\/WAF-1 Gene is involved in chondrogenic differentiation of ATDC5 cells in vitro","volume":"276","author":"Negishi","year":"2001","journal-title":"J Biol Chem"},{"key":"2019041121300782800_B121","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00223-009-9276-0","article-title":"Chondrocyte p21(WAF1\/CIP1) expression is increased by dexamethasone but does not contribute to dexamethasone-induced growth retardation in vivo","volume":"85","author":"Owen","year":"2009","journal-title":"Calcif Tissue Int"},{"key":"2019041121300782800_B122","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1203\/01.pdr.0000232790.53527.c6","article-title":"The role of p27Kip1 in the regulation of growth plate chondrocyte proliferation in mice","volume":"60","author":"Emons","year":"2006","journal-title":"Pediatr Res"},{"key":"2019041121300782800_B123","doi-asserted-by":"crossref","first-page":"e33168","DOI":"10.1371\/journal.pone.0033168","article-title":"Ablation of the pro-apoptotic protein Bax protects mice from glucocorticoid-induced bone growth impairment","volume":"7","author":"Zaman","year":"2012","journal-title":"PLoS One"},{"key":"2019041121300782800_B124","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.toxlet.2013.10.020","article-title":"Dexamethasone differentially regulates Bcl-2 family proteins in human proliferative chondrocytes: role of pro-apoptotic Bid","volume":"224","author":"Zaman","year":"2014","journal-title":"Toxicol Lett"},{"key":"2019041121300782800_B125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/1471-2164-8-205","article-title":"Expression profiling of Dexamethasone-treated primary chondrocytes identifies targets of glucocorticoid signalling in endochondral bone development","volume":"8","author":"James","year":"2007","journal-title":"BMC Genomics"},{"key":"2019041121300782800_B126","doi-asserted-by":"crossref","first-page":"E1023","DOI":"10.1152\/ajpendo.00586.2007","article-title":"Dexamethasone-induced expression of the glucocorticoid response gene lipocalin 2 in chondrocytes","volume":"294","author":"Owen","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121300782800_B127","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1021\/jm020335m","article-title":"Nonsteroidal selective glucocorticoid modulators: the effect of C-10 substitution on receptor selectivity and functional potency of 5-allyl-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines","volume":"46","author":"Kym","year":"2003","journal-title":"J Med Chem"},{"key":"2019041121300782800_B128","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1096\/fj.14-254755","article-title":"Targeting glucocorticoid side effects: selective glucocorticoid receptor modulator or glucocorticoid-induced leucine zipper? A perspective","volume":"28","author":"Ayroldi","year":"2014","journal-title":"FASEB J"},{"key":"2019041121300782800_B129","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1210\/me.2002-0355","article-title":"A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects","volume":"17","author":"Coghlan","year":"2003","journal-title":"Mol Endocrinol"},{"key":"2019041121300782800_B130","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1210\/edrv.18.5.0313","article-title":"Catch-up growth","volume":"18","author":"Boersma","year":"1997","journal-title":"Endocr Rev"},{"key":"2019041121300782800_B131","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000321244","article-title":"Effects of glucocorticoids on the growth plate","volume":"20","author":"Lui","year":"2011","journal-title":"Endocr Dev"},{"key":"2019041121300782800_B132","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0022-3476(63)80035-9","article-title":"Catch-up growth following illness or starvation. An example of developmental canalization in man","volume":"62","author":"Prader","year":"1963","journal-title":"J Pediatr"},{"key":"2019041121300782800_B133","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/adc.72.5.427","article-title":"Catch-up growth in early treated patients with growth hormone deficiency. Dutch Growth Hormone Working Group","volume":"72","author":"Boersma","year":"1995","journal-title":"Arch Dis Child"},{"key":"2019041121300782800_B134","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00005176-199411000-00005","article-title":"Catch-up growth in 60 children with celiac disease","volume":"19","author":"Damen","year":"1994","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019041121300782800_B135","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1210\/endo.135.6.7988472","article-title":"Induction of growth plate cartilage ossification by basic fibroblast growth factor","volume":"135","author":"Baron","year":"1994","journal-title":"Endocrinology"},{"key":"2019041121300782800_B136","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1210\/endo.135.4.7925098","article-title":"Catch-up growth after glucocorticoid excess: a mechanism intrinsic to the growth plate","volume":"135","author":"Baron","year":"1994","journal-title":"Endocrinology"},{"key":"2019041121300782800_B137","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1203\/00006450-200111000-00014","article-title":"Catch-up growth is associated with delayed senescence of the growth plate in rabbits","volume":"50","author":"Gafni","year":"2001","journal-title":"Pediatr Res"},{"key":"2019041121300782800_B138","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/gut.46.5.695","article-title":"Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis","volume":"46","author":"Ballinger","year":"2000","journal-title":"Gut"},{"key":"2019041121300782800_B139","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1586\/eci.10.37","article-title":"Nutritional therapy for the treatment of pediatric Crohn's disease","volume":"6","author":"Otley","year":"2010","journal-title":"Expert Rev Clin Immunol"},{"key":"2019041121300782800_B140","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1210\/endo-104-6-1733","article-title":"Effects of prolonged food deprivation on the ultradian growth hormone rhythm and immunoreactive somatostatin tissue levels in the rat","volume":"104","author":"Tannenbaum","year":"1979","journal-title":"Endocrinology"},{"key":"2019041121300782800_B141","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1210\/mend-4-1-91","article-title":"Effect of fasting on insulin-like growth factor-I (IGF-I) and growth hormone receptor mRNA levels and IGF-I gene transcription in rat liver","volume":"4","author":"Straus","year":"1990","journal-title":"Mol Endocrinol"},{"key":"2019041121300782800_B142","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1677\/joe.0.1220651","article-title":"Regulation of insulin-like growth factor-I and growth hormone receptor gene expression by diabetes and nutritional state in rat tissues","volume":"122","author":"Bornfeldt","year":"1989","journal-title":"J Endocrinol"},{"key":"2019041121300782800_B143","first-page":"960","article-title":"Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects","volume":"78","author":"Bang","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121300782800_B144","first-page":"762","article-title":"The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins","volume":"75","author":"Counts","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121300782800_B145","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1210\/en.2011-1909","article-title":"Role of fibroblast growth factor 21 (FGF21) in undernutrition-related attenuation of growth in mice","volume":"153","author":"Kubicky","year":"2012","journal-title":"Endocrinology"},{"key":"2019041121300782800_B146","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","article-title":"Endocrine regulation of the fasting response by PPAR\u03b1-mediated induction of fibroblast growth factor 21","volume":"5","author":"Inagaki","year":"2007","journal-title":"Cell Metab"},{"key":"2019041121300782800_B147","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cmet.2007.05.010","article-title":"FGF21: a missing link in the biology of fasting","volume":"5","author":"Reitman","year":"2007","journal-title":"Cell Metab"},{"key":"2019041121300782800_B148","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cmet.2008.05.006","article-title":"Inhibition of growth hormone signaling by the fasting-induced hormone FGF21","volume":"8","author":"Inagaki","year":"2008","journal-title":"Cell Metab"},{"key":"2019041121300782800_B149","doi-asserted-by":"crossref","first-page":"27375","DOI":"10.1074\/jbc.M113.462218","article-title":"Increased expression of fibroblast growth factor 21 (FGF21) during chronic undernutrition causes growth hormone insensitivity in chondrocytes by inducing leptin receptor overlapping transcript (LEPROT) and leptin receptor overlapping transcript-like 1 (LEPROTL1) expression","volume":"288","author":"Wu","year":"2013","journal-title":"J Biol Chem"},{"key":"2019041121300782800_B150","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1210\/en.2013-1610","article-title":"A serum component mediates food restriction-induced growth attenuation","volume":"155","author":"Pando","year":"2014","journal-title":"Endocrinology"},{"key":"2019041121300782800_B151","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1172\/JCI119207","article-title":"Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation","volume":"99","author":"De Benedetti","year":"1997","journal-title":"J Clin Invest"},{"key":"2019041121300782800_B152","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1210\/endo.142.11.8511","article-title":"Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis","volume":"142","author":"De Benedetti","year":"2001","journal-title":"Endocrinology"},{"key":"2019041121300782800_B153","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.4049\/jimmunol.166.7.4334","article-title":"In vivo neutralization of human IL-6 (hIL-6) achieved by immunization of hIL-6-transgenic mice with a hIL-6 receptor antagonist","volume":"166","author":"De Benedetti","year":"2001","journal-title":"J Immunol"},{"key":"2019041121300782800_B154","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/S0024-3205(99)00472-5","article-title":"Chronic inflammation inhibits GH secretion and alters the serum insulin-like growth factor system in rats","volume":"65","author":"L\u00f3pez-Calder\u00f3n","year":"1999","journal-title":"Life Sci"},{"key":"2019041121300782800_B155","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1677\/joe.0.1730357","article-title":"Arthritis-induced increase in serum levels of IGF-binding protein-3 in rats is secondary to the decrease in its proteolytic activity","volume":"173","author":"Ib\u00e1\u00f1ez De C\u00e1ceres","year":"2002","journal-title":"J Endocrinol"},{"key":"2019041121300782800_B156","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1677\/joe.0.1650537","article-title":"IGF-I and IGF-I-binding proteins in rats with adjuvant-induced arthritis given recombinant human growth hormone","volume":"165","author":"Iba\u00f1ez De C\u00e1ceres","year":"2000","journal-title":"J Endocrinol"},{"key":"2019041121300782800_B157","doi-asserted-by":"crossref","first-page":"E1656","DOI":"10.1152\/ajpendo.00502.2006","article-title":"Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation","volume":"292","author":"Granado","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121300782800_B158","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/0026-0495(87)90236-8","article-title":"Exogenous growth hormone treatment alters body composition and increases natural killer cell activity in women with impaired endogenous growth hormone secretion","volume":"36","author":"Crist","year":"1987","journal-title":"Metabolism"},{"issue":"suppl 1","key":"2019041121300782800_B159","first-page":"7","article-title":"Fundamental mechanisms of growth failure in inflammatory bowel disease","volume":"58","author":"Ballinger","year":"2002","journal-title":"Horm Res"},{"key":"2019041121300782800_B160","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00005176-199708000-00002","article-title":"Experimental colitis impairs linear bone growth independent of nutritional factors","volume":"25","author":"Koniaris","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019041121300782800_B161","doi-asserted-by":"crossref","first-page":"13260","DOI":"10.1073\/pnas.0503589102","article-title":"Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G\/C polymorphism in children","volume":"102","author":"Sawczenko","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121300782800_B162","doi-asserted-by":"crossref","first-page":"R1483","DOI":"10.1152\/ajpregu.2001.281.5.R1483","article-title":"Delayed puberty and response to testosterone in a rat model of colitis","volume":"281","author":"Azooz","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2019041121300782800_B163","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1203\/PDR.0b013e3181ffee6c","article-title":"Puberty is delayed in male mice with dextran sodium sulfate colitis out of proportion to changes in food intake, body weight, and serum levels of leptin","volume":"69","author":"Deboer","year":"2011","journal-title":"Pediatr Res"},{"key":"2019041121300782800_B164","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00535-009-0192-x","article-title":"Colitis causes delay in puberty in female mice out of proportion to changes in leptin and corticosterone","volume":"45","author":"DeBoer","year":"2010","journal-title":"J Gastroenterol"},{"key":"2019041121300782800_B165","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1210\/endo-127-5-2381","article-title":"Endogenous opioid peptides mediate the interleukin-1-induced inhibition of the release of luteinizing hormone (LH)-releasing hormone and LH","volume":"127","author":"Kalra","year":"1990","journal-title":"Endocrinology"},{"key":"2019041121300782800_B166","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1210\/endo-127-2-849","article-title":"Cytokines act within the brain to inhibit luteinizing hormone secretion and ovulation in the rat","volume":"127","author":"Rivier","year":"1990","journal-title":"Endocrinology"},{"key":"2019041121300782800_B167","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1210\/endo.138.4.5044","article-title":"Effect of immune and metabolic challenges on the luteinizing hormone-releasing hormone neuronal system in cycling female rats: an evaluation at the transcriptional level","volume":"138","author":"Nappi","year":"1997","journal-title":"Endocrinology"},{"key":"2019041121300782800_B168","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.1210\/en.2003-0569","article-title":"Intratesticular delivery of tumor necrosis factor-\u03b1 and ceramide directly abrogates steroidogenic acute regulatory protein expression and Leydig cell steroidogenesis in adult rats","volume":"144","author":"Morales","year":"2003","journal-title":"Endocrinology"},{"key":"2019041121300782800_B169","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1203\/01.pdr.0000196720.25938.be","article-title":"Mouse as a model of growth retardation in cystic fibrosis","volume":"59","author":"Rosenberg","year":"2006","journal-title":"Pediatr Res"},{"key":"2019041121300782800_B170","doi-asserted-by":"crossref","first-page":"G528","DOI":"10.1152\/ajpgi.00052.2011","article-title":"Cystic fibrosis growth retardation is not correlated with loss of Cftr in the intestinal epithelium","volume":"301","author":"Hodges","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2019041121300782800_B171","doi-asserted-by":"crossref","first-page":"20571","DOI":"10.1073\/pnas.1015281107","article-title":"Pigs and humans with cystic fibrosis have reduced insulin-like growth factor 1 (IGF1) levels at birth","volume":"107","author":"Rogan","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121300782800_B172","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ghir.2011.12.003","article-title":"Short-term growth hormone or IGF-I administration improves the IGF-IGFBP system in arthritic rats","volume":"22","author":"L\u00f3pez-Mendui\u00f1a","year":"2012","journal-title":"Growth Horm Igf Res"},{"key":"2019041121300782800_B173","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1053\/gast.2001.22470","article-title":"Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone","volume":"120","author":"Williams","year":"2001","journal-title":"Gastroenterology"},{"key":"2019041121300782800_B174","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/j.gastro.2005.05.018","article-title":"Growth hormone inhibits signal transducer and activator of transcription 3 activation and reduces disease activity in murine colitis","volume":"129","author":"Han","year":"2005","journal-title":"Gastroenterology"},{"key":"2019041121300782800_B175","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/00365529309098257","article-title":"Effect of growth hormone on the inflammatory activity of experimental colitis in rats","volume":"28","author":"Christensen","year":"1993","journal-title":"Scand J Gastroenterol"},{"key":"2019041121300782800_B176","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1053\/j.gastro.2005.02.003","article-title":"Tumor necrosis factor \u03b1 blockade restores growth hormone signaling in murine colitis","volume":"128","author":"DiFedele","year":"2005","journal-title":"Gastroenterology"},{"key":"2019041121300782800_B177","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ibd.21689","article-title":"Innate dysfunction promotes linear growth failure in pediatric Crohn's disease and growth hormone resistance in murine ileitis","volume":"18","author":"D'Mello","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"2019041121300782800_B178","first-page":"1991","article-title":"Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997","volume":"25","author":"Petty","year":"1998","journal-title":"J Rheumatol"},{"key":"2019041121300782800_B179","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.berh.2009.07.003","article-title":"Using biology of disease to understand and guide therapy of JIA","volume":"23","author":"Prakken","year":"2009","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2019041121300782800_B180","doi-asserted-by":"crossref","first-page":"A319","DOI":"10.1016\/j.autrev.2009.11.018","article-title":"Environmental factors and the geoepidemiology of juvenile idiopathic arthritis","volume":"9","author":"Berkun","year":"2010","journal-title":"Autoimmun Rev"},{"key":"2019041121300782800_B181","first-page":"1069","article-title":"Validation of the proposed ILAR classification criteria for juvenile idiopathic arthritis. International League of Associations for Rheumatology","volume":"27","author":"Foeldvari","year":"2000","journal-title":"J Rheumatol"},{"key":"2019041121300782800_B182","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"2019041121300782800_B183","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20460","article-title":"2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features","volume":"63","author":"Beukelman","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2019041121300782800_B184","first-page":"2507","article-title":"Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis","volume":"31","author":"Eberhard","year":"2004","journal-title":"J Rheumatol"},{"key":"2019041121300782800_B185","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3899\/jrheum.110125","article-title":"A dose schedule for intraarticular steroids in juvenile arthritis","volume":"39","author":"Eberhard","year":"2012","journal-title":"J Rheumatol"},{"key":"2019041121300782800_B186","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/acr.21947","article-title":"Delineating the role of multiple intraarticular corticosteroid injections in the management of juvenile idiopathic arthritis in the biologic era","volume":"65","author":"Papadopoulou","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2019041121300782800_B187","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1002\/1529-0131(199911)42:11<2330::AID-ANR11>3.0.CO;2-B","article-title":"Prevention of leg length discrepancy in young children with pauciarticular juvenile rheumatoid arthritis by treatment with intraarticular steroids","volume":"42","author":"Sherry","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2019041121300782800_B188","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s10067-009-1135-x","article-title":"Systemic effects of intra-articular corticosteroids","volume":"28","author":"Habib","year":"2009","journal-title":"Clin Rheumatol"},{"key":"2019041121300782800_B189","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1440-1754.2006.00880.x","article-title":"Cushing syndrome, adrenal suppression and local corticosteroid use","volume":"42","author":"Hameed","year":"2006","journal-title":"J Paediatr Child Health"},{"key":"2019041121300782800_B190","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/rheumatology\/kei154","article-title":"Secondary Cushing's syndrome in children with juvenile idiopathic arthritis following intra-articular triamcinolone acetonide administration","volume":"44","author":"Gondwe","year":"2005","journal-title":"Rheumatology"},{"key":"2019041121300782800_B191","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1542\/peds.113.6.1820","article-title":"Cushing's syndrome after intra-articular and intradermal administration of triamcinolone acetonide in three pediatric patients","volume":"113","author":"Kumar","year":"2004","journal-title":"Pediatrics"},{"key":"2019041121300782800_B192","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-3476(95)70320-9","article-title":"Intraarticular corticosteroids for chronic arthritis in children: efficacy and effects on cartilage and growth","volume":"127","author":"Huppertz","year":"1995","journal-title":"J Pediatr"},{"key":"2019041121300782800_B193","first-page":"95","article-title":"Growth-suppressive effect of intra-articular glucocorticoids detected by knemometry","volume":"52","author":"Heuck","year":"1999","journal-title":"Horm Res"},{"key":"2019041121300782800_B194","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2106\/00004623-198163020-00005","article-title":"Leg-length discrepancies in monoarticular and pauciarticular juvenile rheumatoid arthritis","volume":"63","author":"Simon","year":"1981","journal-title":"J Bone Joint Surg Am"},{"key":"2019041121300782800_B195","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1517\/14656566.2013.783569","article-title":"Juvenile idiopathic arthritis: an update on current pharmacotherapy and future perspectives","volume":"14","author":"Wahezi","year":"2013","journal-title":"Expert Opin Pharmacother"},{"issue":"suppl 1","key":"2019041121300782800_B196","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000229757","article-title":"Juvenile idiopathic arthritis: classification, clinical presentation and current treatments","volume":"72","author":"Dannecker","year":"2009","journal-title":"Horm Res"},{"key":"2019041121300782800_B197","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/art.1780290216","article-title":"A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis","volume":"29","author":"Cassidy","year":"1986","journal-title":"Arthritis Rheum"},{"key":"2019041121300782800_B198","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/art.10444","article-title":"Long-term outcome in patients with juvenile idiopathic arthritis","volume":"46","author":"Minden","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2019041121300782800_B199","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.rdc.2007.07.006","article-title":"Juvenile idiopathic arthritis","volume":"33","author":"Weiss","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"2019041121300782800_B200","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMoa041810","article-title":"Leflunomide or methotrexate for juvenile rheumatoid arthritis","volume":"352","author":"Silverman","year":"2005","journal-title":"N Engl J Med"},{"key":"2019041121300782800_B201","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","article-title":"Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group","volume":"326","author":"Giannini","year":"1992","journal-title":"N Engl J Med"},{"key":"2019041121300782800_B202","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM200003163421103","article-title":"Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group","volume":"342","author":"Lovell","year":"2000","journal-title":"N Engl J Med"},{"key":"2019041121300782800_B203","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1136\/ard.2003.014886","article-title":"The German etanercept registry for treatment of juvenile idiopathic arthritis","volume":"63","author":"Horneff","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"2019041121300782800_B204","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa0706290","article-title":"Adalimumab with or without methotrexate in juvenile rheumatoid arthritis","volume":"359","author":"Lovell","year":"2008","journal-title":"N Engl J Med"},{"key":"2019041121300782800_B205","first-page":"2481","article-title":"Etanercept treatment improves longitudinal growth in prepubertal children with juvenile idiopathic arthritis","volume":"34","author":"Vojvodich","year":"2007","journal-title":"J Rheumatol"},{"key":"2019041121300782800_B206","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/ard.2005.047225","article-title":"Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis","volume":"65","author":"Tynj\u00e4l\u00e4","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2019041121300782800_B207","first-page":"1296","article-title":"Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids","volume":"29","author":"Simon","year":"2002","journal-title":"J Rheumatol"},{"key":"2019041121300782800_B208","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1002\/1529-0131(200011)43:11<2402::AID-ANR5>3.0.CO;2-C","article-title":"Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study","volume":"43","author":"Spiegel","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2019041121300782800_B209","first-page":"935","article-title":"Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis","volume":"32","author":"Kimura","year":"2005","journal-title":"J Rheumatol"},{"key":"2019041121300782800_B210","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/art.20946","article-title":"Targeting the interleukin-6 receptor: a new treatment for systemic juvenile idiopathic arthritis?","volume":"52","author":"de Benedetti","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2019041121300782800_B211","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade","volume":"201","author":"Pascual","year":"2005","journal-title":"J Exp Med"},{"key":"2019041121300782800_B212","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/art.23437","article-title":"The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis","volume":"58","author":"Gattorno","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2019041121300782800_B213","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/RHU.0b013e3181a4f459","article-title":"Anakinra for systemic juvenile arthritis: the Rocky Mountain experience","volume":"15","author":"Zeft","year":"2009","journal-title":"J Clin Rheumatol"},{"key":"2019041121300782800_B214","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/art.30128","article-title":"Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series","volume":"63","author":"Nigrovic","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2019041121300782800_B215","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.2010.134254","article-title":"A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)","volume":"70","author":"Quartier","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2019041121300782800_B216","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/art.1780340912","article-title":"Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis","volume":"34","author":"de Benedetti","year":"1991","journal-title":"Arthritis Rheum"},{"key":"2019041121300782800_B217","doi-asserted-by":"crossref","first-page":"R1281","DOI":"10.1186\/ar1826","article-title":"Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement","volume":"7","author":"Woo","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"2019041121300782800_B218","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","article-title":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial","volume":"371","author":"Yokota","year":"2008","journal-title":"Lancet"},{"key":"2019041121300782800_B219","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/art.38984","article-title":"Catch-up growth during tocilizumab therapy for systemic juvenile idiopathic arthritis: results from a phase III trial","volume":"67","author":"De Benedetti","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2019041121300782800_B220","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/03009741003685624","article-title":"Craniofacial growth disturbance is related to temporomandibular joint abnormality in patients with juvenile idiopathic arthritis, but normal facial profile was also found at the 27-year follow-up","volume":"39","author":"Arvidsson","year":"2010","journal-title":"Scand J Rheumatol"},{"key":"2019041121300782800_B221","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1590\/S0482-50042012000600009","article-title":"Temporomandibular joint alterations and their orofacial complications in patients with juvenile idiopathic arthritis","volume":"52","author":"Carvalho","year":"2012","journal-title":"Rev Bras Reumatol"},{"key":"2019041121300782800_B222","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/rheumatology\/keq329","article-title":"3D analysis of facial asymmetry in subjects with juvenile idiopathic arthritis","volume":"50","author":"Demant","year":"2011","journal-title":"Rheumatology"},{"key":"2019041121300782800_B223","first-page":"663","article-title":"Growth patterns in juvenile rheumatoid arthritis","volume":"21","author":"Liem","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"2019041121300782800_B224","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1651-2227.1999.tb00032.x","article-title":"Growth of prepubertal children with juvenile chronic arthritis","volume":"88","author":"Saha","year":"1999","journal-title":"Acta Paediatrica"},{"key":"2019041121300782800_B225","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jpeds.2011.04.012","article-title":"Children with oligoarticular juvenile idiopathic arthritis are at considerable risk for growth retardation","volume":"159","author":"Padeh","year":"2011","journal-title":"J Pediatr"},{"key":"2019041121300782800_B226","first-page":"2337","article-title":"Magnetic resonance imaging identifies features in clinically unaffected knees predicting extension of arthritis in children with monoarthritis","volume":"33","author":"Gardner-Medwin","year":"2006","journal-title":"J Rheumatol"},{"key":"2019041121300782800_B227","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/03009749709115826","article-title":"Growth retardation in non-steroid treated juvenile rheumatoid arthritis","volume":"26","author":"Polito","year":"1997","journal-title":"Scand J Rheumatol"},{"key":"2019041121300782800_B228","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3899\/jrheum.120386","article-title":"Patients with very early-onset systemic juvenile idiopathic arthritis exhibit more inflammatory features and a worse outcome","volume":"40","author":"Russo","year":"2013","journal-title":"J Rheumatol"},{"key":"2019041121300782800_B229","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00296-010-1473-7","article-title":"Sexual maturation in boys with juvenile rheumatoid arthritis","volume":"31","author":"Aggarwal","year":"2011","journal-title":"Rheumatol Int"},{"key":"2019041121300782800_B230","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1007\/s00296-013-2683-6","article-title":"Sexual maturation in Egyptian boys and girls with juvenile rheumatoid arthritis","volume":"33","author":"Maher","year":"2013","journal-title":"Rheumatol Int"},{"key":"2019041121300782800_B231","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00296-009-1332-6","article-title":"Longitudinal growth attainments of Indian boys with juvenile rheumatoid arthritis","volume":"31","author":"Aggarwal","year":"2011","journal-title":"Rheumatol Int"},{"issue":"suppl 2","key":"2019041121300782800_B232","first-page":"285","article-title":"Age at menarche in juvenile rheumatoid arthritis","volume":"16","author":"Rusconi","year":"2003","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2019041121300782800_B233","first-page":"194","article-title":"Growth and menarche during remission in children with juvenile idiopathic arthritis","volume":"13","author":"Um\u0142awska","year":"2009","journal-title":"Med Wieku Rozwoj"},{"key":"2019041121300782800_B234","first-page":"1783","article-title":"Sex, reproduction, and gynecological disease in young adults with a history of juvenile chronic arthritis","volume":"27","author":"Ostensen","year":"2000","journal-title":"J Rheumatol"},{"key":"2019041121300782800_B235","first-page":"308","article-title":"The natural history of juvenile chronic arthritis: a population based cohort study. II. Outcome","volume":"22","author":"G\u00e4re","year":"1995","journal-title":"J Rheumatol"},{"key":"2019041121300782800_B236","first-page":"80","article-title":"Final height, armspan, subischial leg length and body proportions in juvenile chronic arthritis. A long-term follow-up study","volume":"52","author":"Zak","year":"1999","journal-title":"Horm Res"},{"key":"2019041121300782800_B237","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s100670200098","article-title":"Attained adult height in juvenile rheumatoid arthritis with or without corticosteroid treatment","volume":"21","author":"Wang","year":"2002","journal-title":"Clin Rheumatol"},{"issue":"suppl 1","key":"2019041121300782800_B238","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000229759","article-title":"Adult outcomes of patients with juvenile idiopathic arthritis","volume":"72","author":"Minden","year":"2009","journal-title":"Horm Res"},{"key":"2019041121300782800_B239","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/rheumatology\/41.12.1440","article-title":"Long-term follow-up of 246 adults with juvenile idiopathic arthritis: social function, relationships and sexual activity","volume":"41","author":"Packham","year":"2002","journal-title":"Rheumatology"},{"key":"2019041121300782800_B240","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1002\/art.22048","article-title":"A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus","volume":"54","author":"Guti\u00e9rrez-Su\u00e1rez","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2019041121300782800_B241","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/annrheumdis-2011-200106","article-title":"A longitudinal PRINTO study on growth and puberty in juvenile systemic lupus erythematosus","volume":"71","author":"Rygg","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2019041121300782800_B242","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/03009749209099216","article-title":"Nutrient intake and nutritional status in children with juvenile chronic arthritis","volume":"21","author":"Haugen","year":"1992","journal-title":"Scand J Rheumatol"},{"key":"2019041121300782800_B243","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00005176-199803000-00013","article-title":"Growth of prepubertal children with inflammatory bowel disease","volume":"26","author":"Saha","year":"1998","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019041121300782800_B244","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.3899\/jrheum.080199","article-title":"Growth velocity and interleukin 6 concentrations in juvenile idiopathic arthritis","volume":"35","author":"Souza","year":"2008","journal-title":"J Rheumatol"},{"key":"2019041121300782800_B245","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1054\/ghir.1999.0099","article-title":"Study of growth hormone secretion and action in growth-retarded children with juvenile chronic arthritis (JCA)","volume":"9","author":"Tsatsoulis","year":"1999","journal-title":"Growth Horm Igf Res"},{"key":"2019041121300782800_B246","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/ard.50.9.602","article-title":"Insulin-like growth factor and growth hormone secretion in juvenile chronic arthritis","volume":"50","author":"Allen","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"2019041121300782800_B247","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/art.1780400218","article-title":"Juvenile rheumatoid arthritis. Effects of disease activity and recombinant human growth hormone on insulin-like growth factor 1, insulin-like growth factor binding proteins 1 and 3, and osteocalcin","volume":"40","author":"Davies","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2019041121300782800_B248","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000334646","article-title":"Changes in growth hormone receptor gene expression during therapy in children with juvenile idiopathic arthritis","volume":"77","author":"Bozzola","year":"2012","journal-title":"Horm Res Paediatr"},{"key":"2019041121300782800_B249","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ghir.2012.07.002","article-title":"Total pubertal growth in patients with juvenile idiopathic arthritis treated with growth hormone: analysis of a single center","volume":"22","author":"Bechtold","year":"2012","journal-title":"Growth Horm Igf Res"},{"key":"2019041121300782800_B250","first-page":"1413","article-title":"Growth hormone is effective in the treatment of severe growth retardation in children with juvenile chronic arthritis. Double blind placebo-controlled followup study","volume":"31","author":"Saha","year":"2004","journal-title":"J Rheumatol"},{"key":"2019041121300782800_B251","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/archdischild-2014-307228","article-title":"Controversies in the diagnosis and management of growth hormone deficiency in childhood and adolescence","volume":"101","author":"Murray","year":"2016","journal-title":"Arch Dis Child"},{"key":"2019041121300782800_B252","first-page":"3990","article-title":"Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society","volume":"85","author":"Growth Hormone Research Society","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121300782800_B253","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1677\/joe.0.1590239","article-title":"Effects of endotoxin lipopolysaccharide administration on the somatotropic axis","volume":"159","author":"Soto","year":"1998","journal-title":"J Endocrinol"},{"key":"2019041121300782800_B254","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ghir.2008.01.006","article-title":"Inflammatory cytokines in juvenile idiopathic arthritis: effects on physical growth and the insulin-like-growth factor axis","volume":"18","author":"Wong","year":"2008","journal-title":"Growth Horm Igf Res"},{"key":"2019041121300782800_B255","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/adc.2004.069138","article-title":"Growth hormone treatment in children with rheumatic disease, corticosteroid induced growth retardation, and osteopenia","volume":"91","author":"Grote","year":"2006","journal-title":"Arch Dis Child"},{"key":"2019041121300782800_B256","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/ard.2005.040816","article-title":"Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3","volume":"65","author":"Sarzi-Puttini","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2019041121300782800_B257","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1515\/JPEM.2000.13.7.899","article-title":"Efficacy of recombinant human growth hormone in children with juvenile rheumatoid arthritis and growth failure","volume":"13","author":"Al-Mutair","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2019041121300782800_B258","first-page":"1407","article-title":"Bone mass development and bone metabolism in juvenile idiopathic arthritis: treatment with growth hormone for 4 years","volume":"31","author":"Bechtold","year":"2004","journal-title":"J Rheumatol"},{"key":"2019041121300782800_B259","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00441894","article-title":"Rheumatoid arthritis and growth retardation in children: treatment with human growth hormone","volume":"130","author":"Butenandt","year":"1979","journal-title":"Eur J Pediatr"},{"key":"2019041121300782800_B260","first-page":"153","article-title":"Treatment of growth retardation in juvenile chronic arthritis with recombinant human growth hormone","volume":"21","author":"Davies","year":"1994","journal-title":"J Rheumatol"},{"key":"2019041121300782800_B261","first-page":"2492","article-title":"Effects on growth and body composition of growth hormone treatment in children with juvenile idiopathic arthritis requiring steroid therapy","volume":"30","author":"Simon","year":"2003","journal-title":"J Rheumatol"},{"issue":"suppl 6","key":"2019041121300782800_B262","first-page":"47","article-title":"Treatment of growth failure with human growth hormone in patients with juvenile chronic arthritis. A pilot study","volume":"9","author":"Svantesson","year":"1991","journal-title":"Clin Exp Rheumatol"},{"key":"2019041121300782800_B263","first-page":"403","article-title":"Beneficial effects of one-year growth hormone administration to children with juvenile chronic arthritis on chronic steroid therapy. I. Effects on growth velocity and body composition [published correction appears in J Clin Endocrinol Metab. 1998;83(5):1547]","volume":"83","author":"Touati","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121300782800_B264","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1651-2227.1999.tb14363.x","article-title":"Growth hormone treatment of short stature and metabolic dysfunction in juvenile chronic arthritis","volume":"88","author":"Simon","year":"1999","journal-title":"Acta Paediatr Suppl"},{"key":"2019041121300782800_B265","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1067\/S0022-3476(03)00390-1","article-title":"Growth hormone improves height in patients with juvenile idiopathic arthritis: 4-year data of a controlled study","volume":"143","author":"Bechtold","year":"2003","journal-title":"J Pediatr"},{"key":"2019041121300782800_B266","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.1210\/jcem.86.12.8083","article-title":"GH therapy in juvenile chronic arthritis: results of a two-year controlled study on growth and bone","volume":"86","author":"Bechtold","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121300782800_B267","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1172\/JCI116212","article-title":"Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously","volume":"91","author":"Kupfer","year":"1993","journal-title":"J Clin Invest"},{"key":"2019041121300782800_B268","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1210\/jc.2006-2877","article-title":"Early recombinant human growth hormone treatment in glucocorticoid-treated children with juvenile idiopathic arthritis: a 3-year randomized study","volume":"92","author":"Simon","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121300782800_B269","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1651-2227.2008.00845.x","article-title":"Growth hormone treatment in short children with chronic kidney disease","volume":"97","author":"Mehls","year":"2008","journal-title":"Acta Paediatr"},{"key":"2019041121300782800_B270","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00467-006-0020-y","article-title":"Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement","volume":"21","author":"Mahan","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"2019041121300782800_B271","first-page":"1","article-title":"Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development","volume":"52","author":"Prader","year":"1989","journal-title":"Helv Paediatr Acta Suppl"},{"key":"2019041121300782800_B272","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000324117","article-title":"Observed and predicted total pubertal growth during treatment with growth hormone in adolescents with idiopathic growth hormone deficiency, Turner syndrome, short stature, born small for gestational age and idiopathic short stature: KIGS analysis and review","volume":"75","author":"Ranke","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"2019041121300782800_B273","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0016-5085(98)70381-6","article-title":"Inflammatory bowel disease: etiology and pathogenesis","volume":"115","author":"Fiocchi","year":"1998","journal-title":"Gastroenterology"},{"key":"2019041121300782800_B274","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature06005","article-title":"Unravelling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier","year":"2007","journal-title":"Nature"},{"key":"2019041121300782800_B275","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(99)02625-2","article-title":"Incidence of paediatric Crohn's disease in Stockholm, Sweden","volume":"354","author":"Askling","year":"1999","journal-title":"Lancet"},{"key":"2019041121300782800_B276","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jpeds.2004.08.043","article-title":"Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry","volume":"146","author":"Heyman","year":"2005","journal-title":"J Pediatr"},{"key":"2019041121300782800_B277","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1136\/gut.52.10.1432","article-title":"Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990\u20132001","volume":"52","author":"Hildebrand","year":"2003","journal-title":"Gut"},{"key":"2019041121300782800_B278","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1067\/S0022-3476(03)00444-X","article-title":"Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study","volume":"143","author":"Kugathasan","year":"2003","journal-title":"J Pediatr"},{"key":"2019041121300782800_B279","doi-asserted-by":"crossref","first-page":"18129","DOI":"10.1073\/pnas.0505256102","article-title":"Reduced Paneth cell \u03b1-defensins in ileal Crohn's disease","volume":"102","author":"Wehkamp","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121300782800_B280","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1001\/jama.292.22.2708","article-title":"Scientists explore pathogenesis of IBD","volume":"292","author":"Hampton","year":"2004","journal-title":"JAMA"},{"key":"2019041121300782800_B281","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/379821a0","article-title":"Mapping of a susceptibility locus for Crohn's disease on chromosome 16","volume":"379","author":"Hugot","year":"1996","journal-title":"Nature"},{"key":"2019041121300782800_B282","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0140-6736(06)68345-1","article-title":"New genes in inflammatory bowel disease: lessons for complex diseases?","volume":"367","author":"Gaya","year":"2006","journal-title":"Lancet"},{"key":"2019041121300782800_B283","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.3748\/wjg.v12.i13.1991","article-title":"Novel susceptibility genes in inflammatory bowel disease","volume":"12","author":"Noble","year":"2006","journal-title":"World J Gastroenterol"},{"key":"2019041121300782800_B284","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/adc.2003.041046","article-title":"Unravelling the complex genetics of inflammatory bowel disease","volume":"89","author":"Russell","year":"2004","journal-title":"Arch Dis Child"},{"key":"2019041121300782800_B285","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/gut.2005.082107","article-title":"Analysis of the influence of OCTN1\/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease","volume":"55","author":"Russell","year":"2006","journal-title":"Gut"},{"key":"2019041121300782800_B286","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1572-0241.2005.41737.x","article-title":"TNF promoter polymorphisms and modulation of growth retardation and disease severity in pediatric Crohn's disease","volume":"100","author":"Levine","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"2019041121300782800_B287","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1469-1809.2010.00606.x","article-title":"Association of linear growth impairment in pediatric Crohn's disease and a known height locus: a pilot study","volume":"74","author":"Lee","year":"2010","journal-title":"Ann Hum Genet"},{"key":"2019041121300782800_B288","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s40272-014-0070-8","article-title":"Pediatric ulcerative colitis: a practical guide to management","volume":"16","author":"Regan","year":"2014","journal-title":"Paediatr Drugs"},{"key":"2019041121300782800_B289","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/archdischild-2013-305512","article-title":"Ulcerative colitis: management in adults, children and young people (NICE Clinical Guideline CG166)","volume":"99","author":"Stenke","year":"2014","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"2019041121300782800_B290","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000228564","article-title":"Enteral nutrition should be used to induce remission in childhood Crohn's disease","volume":"27","author":"Heuschkel","year":"2009","journal-title":"Dig Dis"},{"key":"2019041121300782800_B291","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000360717","article-title":"Effects of exclusive enteral nutrition on bone mass, linear growth and body composition in children with Crohn's disease","volume":"79","author":"Sylvester","year":"2014","journal-title":"Nestle Nutr Inst Workshop Ser"},{"key":"2019041121300782800_B292","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/ecco-jcc\/jjv031","article-title":"Methotrexate for maintaining remission in paediatric Crohn's patients with prior failure or intolerance to thiopurines: a multicenter cohort study","volume":"9","author":"Haisma","year":"2015","journal-title":"J Crohns Colitis"},{"key":"2019041121300782800_B293","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/MOP.0b013e3283574154","article-title":"The use of biologic agents in pediatric inflammatory bowel disease","volume":"24","author":"Yang","year":"2012","journal-title":"Curr Opin Pediatr"},{"key":"2019041121300782800_B294","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/cid\/cit489","article-title":"Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor-\u03b1 inhibitors: systematic review of the literature","volume":"57","author":"Toussi","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2019041121300782800_B295","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/MPG.0b013e3181957a11","article-title":"Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease: update","volume":"48","author":"Mackey","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019041121300782800_B296","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/MPG.0b013e3181edd797","article-title":"Improvement in growth of children with Crohn disease following anti-TNF-\u03b1 therapy can be independent of pubertal progress and glucocorticoid reduction","volume":"52","author":"Malik","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019041121300782800_B297","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.crohns.2011.09.004","article-title":"The effects of anti-TNF-\u03b1 treatment with adalimumab on growth in children with Crohn's disease (CD)","volume":"6","author":"Malik","year":"2012","journal-title":"J Crohns Colitis"},{"key":"2019041121300782800_B298","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/MIB.0000000000000083","article-title":"Infliximab maintains durable response and facilitates catch-up growth in luminal pediatric Crohn's disease","volume":"20","author":"Church","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"2019041121300782800_B299","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40272-013-0046-0","article-title":"Endocrine therapy for growth retardation in paediatric inflammatory bowel disease","volume":"16","author":"Altowati","year":"2014","journal-title":"Paediatr Drugs"},{"key":"2019041121300782800_B300","doi-asserted-by":"crossref","first-page":"e1278","DOI":"10.1542\/peds.2008-2306","article-title":"Indeterminate colitis: a distinctive clinical pattern of inflammatory bowel disease in children","volume":"122","author":"Romano","year":"2008","journal-title":"Pediatrics"},{"key":"2019041121300782800_B301","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1007\/s00467-005-1973-y","article-title":"Bone mineral content, corrected for height or bone area, measured by DXA is not reduced in children with chronic renal disease or in hypoparathyroidism","volume":"20","author":"Ahmed","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"2019041121300782800_B302","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/MCG.0b013e318247c32f","article-title":"Natural history of pediatric-onset inflammatory bowel disease: a systematic review","volume":"46","author":"Abraham","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"2019041121300782800_B303","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00005176-199402000-00008","article-title":"Longitudinal growth in children and adolescents with inflammatory bowel disease","volume":"18","author":"Hildebrand","year":"1994","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019041121300782800_B304","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0016-5085(93)90883-E","article-title":"Growth failure in children with inflammatory bowel disease: a prospective study","volume":"105","author":"Motil","year":"1993","journal-title":"Gastroenterology"},{"key":"2019041121300782800_B305","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/MPG.0b013e3181596efd","article-title":"Natural history of paediatric inflammatory bowel diseases over a 5-year follow-up: a retrospective review of data from the register of paediatric inflammatory bowel diseases","volume":"46","author":"Newby","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019041121300782800_B306","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/MPG.0b013e318175ca7f","article-title":"Growth abnormalities persist in newly diagnosed children with Crohn disease despite current treatment paradigms","volume":"48","author":"Pfefferkorn","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019041121300782800_B307","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1038\/ajg.2010.20","article-title":"Nutritional status and growth in pediatric Crohn's disease: a population-based study","volume":"105","author":"Vasseur","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"2019041121300782800_B308","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s10620-011-1954-x","article-title":"Serum antibodies and anthropometric data at diagnosis in pediatric Crohn's disease","volume":"57","author":"Trauernicht","year":"2012","journal-title":"Dig Dis Sci"},{"key":"2019041121300782800_B309","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0016-5085(88)80072-6","article-title":"Decreased height velocity in children and adolescents before the diagnosis of Crohn's disease","volume":"95","author":"Kanof","year":"1988","journal-title":"Gastroenterology"},{"key":"2019041121300782800_B310","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpeds.2013.02.010","article-title":"Delays in puberty, growth, and accrual of bone mineral density in pediatric Crohn's disease: despite temporal changes in disease severity, the need for monitoring remains","volume":"163","author":"DeBoer","year":"2013","journal-title":"J Pediatr"},{"key":"2019041121300782800_B311","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0950-3528(06)80020-5","article-title":"Growth and puberty in chronic inflammatory bowel disease","volume":"8","author":"Brain","year":"1994","journal-title":"Baillieres Clin Gastroenterol"},{"key":"2019041121300782800_B312","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/MPG.0b013e31821898ae","article-title":"Late adolescent linear growth pattern in pediatric-onset inflammatory bowel disease","volume":"53","author":"Hood","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019041121300782800_B313","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1007\/s10620-012-2235-z","article-title":"Menarche in pediatric patients with Crohn's disease","volume":"57","author":"Gupta","year":"2012","journal-title":"Dig Dis Sci"},{"key":"2019041121300782800_B314","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/bmj.308.6939.1259","article-title":"Juvenile onset inflammatory bowel disease: height and body mass index in adult life","volume":"308","author":"Ferguson","year":"1994","journal-title":"BMJ"},{"key":"2019041121300782800_B315","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/ibd.21617","article-title":"Sex differences in statural growth impairment in Crohn's disease: role of IGF-1","volume":"17","author":"Gupta","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"2019041121300782800_B316","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0022-3468(80)80754-8","article-title":"Crohn's disease in children: assessment of the progression of disease, growth, and prognosis","volume":"15","author":"Castile","year":"1980","journal-title":"J Pediatr Surg"},{"key":"2019041121300782800_B317","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00005176-199305000-00005","article-title":"Growth failure in pediatric inflammatory bowel disease","volume":"16","author":"Markowitz","year":"1993","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019041121300782800_B318","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/gut.51.1.26","article-title":"Adult height in patients with early onset of Crohn's disease","volume":"51","author":"Alemzadeh","year":"2002","journal-title":"Gut"},{"key":"2019041121300782800_B319","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/ibd.21214","article-title":"Final adult height of children with inflammatory bowel disease is predicted by parental height and patient minimum height Z-score","volume":"16","author":"Lee","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"2019041121300782800_B320","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5223\/pghn.2014.17.3.147","article-title":"Gender differences in paediatric patients of the Swiss inflammatory bowel disease cohort study","volume":"17","author":"Herzog","year":"2014","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"2019041121300782800_B321","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00005176-199307000-00011","article-title":"Dietary intake and nutritional treatment in childhood Crohn's disease","volume":"17","author":"Thomas","year":"1993","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019041121300782800_B322","first-page":"CD003873","article-title":"Interventions for growth failure in childhood Crohn's disease","volume":"3","author":"Newby","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"2019041121300782800_B323","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/apt.12230","article-title":"Clinical progress in the two years following a course of exclusive enteral nutrition in 109 paediatric patients with Crohn's disease","volume":"37","author":"Cameron","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"2019041121300782800_B324","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/01.mpg.0000189137.06151.33","article-title":"Infliximab dependency in a national cohort of children with Crohn's disease","volume":"42","author":"Wewer","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019041121300782800_B325","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1440-1746.2009.06195.x","article-title":"Infliximab improves inflammation and anthropometric measures in pediatric Crohn's disease","volume":"25","author":"Sinitsky","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"2019041121300782800_B326","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1053\/gast.2000.18144","article-title":"A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease","volume":"119","author":"Markowitz","year":"2000","journal-title":"Gastroenterology"},{"key":"2019041121300782800_B327","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/MPG.0b013e31805b82c6","article-title":"Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease","volume":"45","author":"Navarro","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019041121300782800_B328","first-page":"159","article-title":"Relationships between serum IGF-1, IGFBP-2, interleukin-1\u03b2 and interleukin-6 in inflammatory bowel disease","volume":"61","author":"Street","year":"2004","journal-title":"Horm Res"},{"key":"2019041121300782800_B329","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ibd.21132","article-title":"Lipopolysaccharide exposure is linked to activation of the acute phase response and growth failure in pediatric Crohn's disease and murine colitis","volume":"16","author":"Pasternak","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"2019041121300782800_B330","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1210\/jcem-44-4-622","article-title":"Basal and stimulated serum growth hormone concentrations in inflammatory bowel disease","volume":"44","author":"Tenore","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121300782800_B331","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/0016-5085(86)90683-9","article-title":"Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease","volume":"91","author":"Kirschner","year":"1986","journal-title":"Gastroenterology"},{"key":"2019041121300782800_B332","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00005176-198409000-00009","article-title":"Endocrine dysfunction in children with Crohn's disease","volume":"3","author":"Chong","year":"1984","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019041121300782800_B333","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/gut.22.11.933","article-title":"Nocturnal growth hormone and gonadotrophin secretion in growth retarded children with Crohn's disease","volume":"22","author":"Farthing","year":"1981","journal-title":"Gut"},{"key":"2019041121300782800_B334","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0002-9270(01)04110-7","article-title":"Low free and total insulinlike growth factor I (IGF-I) and IGF binding protein-3 levels in chronic inflammatory bowel disease: partial normalization during prednisolone treatment","volume":"97","author":"Gr\u00f8nbek","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"2019041121300782800_B335","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005176-200403000-00007","article-title":"Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease","volume":"38","author":"Bannerjee","year":"2004","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019041121300782800_B336","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1365-2265.1998.00562.x","article-title":"Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Crohn's disease","volume":"49","author":"Beattie","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121300782800_B337","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1080\/00365520601010115","article-title":"The insulin-like growth factor (IGF) system and its relation to infliximab treatment in adult patients with Crohn's disease","volume":"42","author":"Eivindson","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"2019041121300782800_B338","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-2265.2010.03799.x","article-title":"The growth hormone insulin-like growth factor 1 axis in children and adolescents with inflammatory bowel disease and growth retardation","volume":"73","author":"Wong","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121300782800_B339","doi-asserted-by":"crossref","first-page":"e1418","DOI":"10.1542\/peds.2007-0905","article-title":"Gender differences in presentation and course of disease in pediatric patients with Crohn disease","volume":"120","author":"Gupta","year":"2007","journal-title":"Pediatrics"},{"key":"2019041121300782800_B340","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1046\/j.1523-1755.2002.00603.x","article-title":"Differential effects of insulin-like growth factor binding proteins-1, -2, -3, and -6 on cultured growth plate chondrocytes","volume":"62","author":"Kiepe","year":"2002","journal-title":"Kidney Int"},{"key":"2019041121300782800_B341","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1210\/endo.140.12.7169","article-title":"Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain","volume":"140","author":"Hoeflich","year":"1999","journal-title":"Endocrinology"},{"key":"2019041121300782800_B342","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF01255604","article-title":"Effect of administered human growth hormone on growth retardation in inflammatory bowel disease","volume":"19","author":"McCaffery","year":"1974","journal-title":"Am J Dig Dis"},{"key":"2019041121300782800_B343","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/BF02532536","article-title":"Therapy with recombinant growth hormone in children with Crohn disease and growth failure","volume":"155","author":"Henker","year":"1996","journal-title":"Eur J Pediatr"},{"key":"2019041121300782800_B344","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1053\/meta.2002.28972","article-title":"Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study","volume":"51","author":"Mauras","year":"2002","journal-title":"Metabolism"},{"key":"2019041121300782800_B345","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1515\/JPEM.2007.20.12.1315","article-title":"The effects of recombinant human growth hormone on linear growth in children with Crohn's disease and short stature","volume":"20","author":"Wong","year":"2007","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2019041121300782800_B346","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jpeds.2008.04.064","article-title":"Growth hormone treatment for growth failure in pediatric patients with Crohn's disease","volume":"153","author":"Heyman","year":"2008","journal-title":"J Pediatr"},{"key":"2019041121300782800_B347","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM200006013422203","article-title":"A preliminary study of growth hormone therapy for Crohn's disease","volume":"342","author":"Slonim","year":"2000","journal-title":"N Engl J Med"},{"key":"2019041121300782800_B348","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/07315724.2009.10719782","article-title":"Effect of exclusion diet with nutraceutical therapy in juvenile Crohn's disease","volume":"28","author":"Slonim","year":"2009","journal-title":"J Am Coll Nutr"},{"key":"2019041121300782800_B349","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/01.MIB.0000159321.58773.a6","article-title":"Effect of recombinant growth hormone treatment on children with Crohn's disease and short stature: a pilot study","volume":"11","author":"Calenda","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"2019041121300782800_B350","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/MPG.0b013e3181c992d6","article-title":"A randomized controlled trial of growth hormone in active pediatric Crohn disease","volume":"51","author":"Denson","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019041121300782800_B351","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2265.2011.03977.x","article-title":"A preliminary trial of the effect of recombinant human growth hormone on short-term linear growth and glucose homeostasis in children with Crohn's disease","volume":"74","author":"Wong","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121300782800_B352","first-page":"27","article-title":"The inflammatory milieu and the insulin like growth factor axis in children with inflammatory bowel disease following recombinant human growth hormone treatment","volume":"29","author":"Wong","year":"2015","journal-title":"J Biol Regul Homeost Agents"},{"key":"2019041121300782800_B353","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/00054725-200403000-00008","article-title":"The effect of recombinant human growth hormone (rhGH) on trinitrobenzene sulfonic acid-induced colitis in rats: an experimental study","volume":"10","author":"Kara","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"2019041121300782800_B354","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ghir.2007.01.002","article-title":"TNF-\u03b1 levels in children with growth hormone deficiency and the effect of long-term growth hormone replacement therapy","volume":"17","author":"Andiran","year":"2007","journal-title":"Growth Horm Igf Res"},{"key":"2019041121300782800_B355","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1530\/eje.0.1380640","article-title":"Modulating effect of human growth hormone on tumour necrosis factor-\u03b1 and interleukin-1\u03b2","volume":"138","author":"Bozzola","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"2019041121300782800_B356","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1530\/eje.0.1490397","article-title":"Stimulating effect of growth hormone on cytokine release in children","volume":"149","author":"Bozzola","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"2019041121300782800_B357","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1530\/eje.1.01827","article-title":"Serum cytokine levels in GH-deficient children during substitutive GH therapy","volume":"152","author":"Pagani","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"2019041121300782800_B358","first-page":"65","article-title":"Effect of growth hormone therapy on the proinflammatory cytokine profile in growth hormone-deficient children","volume":"16","author":"Pagani","year":"2005","journal-title":"Eur Cytokine Netw"},{"key":"2019041121300782800_B359","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00005176-199105000-00005","article-title":"Development and validation of a pediatric Crohn's disease activity index","volume":"12","author":"Hyams","year":"1991","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019041121300782800_B360","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1203\/00006450-199308000-00011","article-title":"Circulating tumor necrosis factor-\u03b1 levels and lipid abnormalities in patients with cystic fibrosis","volume":"34","author":"Levy","year":"1993","journal-title":"Pediatr Res"},{"key":"2019041121300782800_B361","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1164\/ajrccm.157.6.9704086","article-title":"Circulating immunoreactive interleukin-6 in cystic fibrosis","volume":"157","author":"Nixon","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"2019041121300782800_B362","first-page":"87","article-title":"TNF-\u03b1 polymorphisms as a potential modifier gene in the cystic fibrosis","volume":"5","author":"Coutinho","year":"2014","journal-title":"Int J Mol Epidemiol Genet"},{"key":"2019041121300782800_B363","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1479-5876-11-19","article-title":"TNF gene polymorphisms in cystic fibrosis patients: contribution to the disease progression","volume":"11","author":"Shmarina","year":"2013","journal-title":"J Transl Med"},{"key":"2019041121300782800_B364","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jcf.2014.04.007","article-title":"Cytokine gene polymorphisms and severity of CF lung disease","volume":"13","author":"de Vries","year":"2014","journal-title":"J Cyst Fibros"},{"key":"2019041121300782800_B365","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1530\/eje.1.02064","article-title":"Inflammation is a modulator of the insulin-like growth factor (IGF)\/IGF-binding protein system inducing reduced bioactivity of IGFs in cystic fibrosis","volume":"154","author":"Street","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"2019041121300782800_B366","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2265.2008.03387.x","article-title":"The IGF system and cytokine interactions and relationships with longitudinal growth in prepubertal patients with cystic fibrosis","volume":"70","author":"Street","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121300782800_B367","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MPG.0000000000000683","article-title":"Intestinal inflammation and impact on growth in children with cystic fibrosis","volume":"60","author":"Dhaliwal","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019041121300782800_B368","first-page":"66","article-title":"The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report","volume":"19","author":"Walicka-Serzysko","year":"2015","journal-title":"Dev Period Med"},{"key":"2019041121300782800_B369","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/INF.0000000000000231","article-title":"Aspergillus sensitization or carriage in cystic fibrosis patients","volume":"33","author":"Fillaux","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"2019041121300782800_B370","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/1753465812443094","article-title":"Management of allergic bronchopulmonary aspergillosis: a review and update","volume":"6","author":"Mahdavinia","year":"2012","journal-title":"Ther Adv Respir Dis"},{"key":"2019041121300782800_B371","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcf.2008.07.005","article-title":"Early referral to cystic fibrosis specialist centre impacts on respiratory outcome","volume":"8","author":"Lebecque","year":"2009","journal-title":"J Cyst Fibros"},{"key":"2019041121300782800_B372","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jcf.2011.03.003","article-title":"Comparison of height for age and height for bone age with and without adjustment for target height in pediatric patients with CF","volume":"10","author":"Woestenenk","year":"2011","journal-title":"J Cyst Fibros"},{"key":"2019041121300782800_B373","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/adc.81.3.241","article-title":"Normal growth in cystic fibrosis associated with a specialised centre","volume":"81","author":"Collins","year":"1999","journal-title":"Arch Dis Child"},{"key":"2019041121300782800_B374","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/bmj.316.7147.1771","article-title":"Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study","volume":"316","author":"Mahadeva","year":"1998","journal-title":"BMJ"},{"key":"2019041121300782800_B375","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/MPG.0b013e31818f0a39","article-title":"Growth assessment of paediatric patients with CF comparing different auxologic indicators: a multicentre Italian study","volume":"49","author":"Lucidi","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019041121300782800_B376","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/apa.12462","article-title":"The relationship between body growth and pulmonary function in children with cystic fibrosis","volume":"103","author":"Woestenenk","year":"2014","journal-title":"Acta Paediatr"},{"key":"2019041121300782800_B377","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1067\/mpd.2000.107891","article-title":"Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry","volume":"137","author":"Zemel","year":"2000","journal-title":"J Pediatr"},{"key":"2019041121300782800_B378","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/BF01958975","article-title":"Perspectives of longitudinal growth in cystic fibrosis from birth to adult age","volume":"153","author":"Haeusler","year":"1994","journal-title":"Eur J Pediatr"},{"key":"2019041121300782800_B379","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/archdischild-2011-301069","article-title":"Growth during puberty in cystic fibrosis: a retrospective evaluation of a French cohort","volume":"97","author":"Bournez","year":"2012","journal-title":"Arch Dis Child"},{"key":"2019041121300782800_B380","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0022-3476(85)80130-X","article-title":"Effects of long-term nutritional rehabilitation on body composition and clinical status in malnourished children and adolescents with cystic fibrosis","volume":"107","author":"Levy","year":"1985","journal-title":"J Pediatr"},{"key":"2019041121300782800_B381","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0022-3476(86)80695-3","article-title":"Nutritional rehabilitation in cystic fibrosis: controlled studies of effects on nutritional growth retardation, body protein turnover, and course of pulmonary disease","volume":"109","author":"Shepherd","year":"1986","journal-title":"J Pediatr"},{"key":"2019041121300782800_B382","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00005176-199208000-00007","article-title":"Nutritional rehabilitation in cystic fibrosis: a 5 year follow-up study","volume":"15","author":"Dalzell","year":"1992","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019041121300782800_B383","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0002-8223(99)00046-2","article-title":"Nutritional effects of long-term gastrostomy feedings in children with cystic fibrosis","volume":"99","author":"Rosenfeld","year":"1999","journal-title":"J Am Diet Assoc"},{"key":"2019041121300782800_B384","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ppul.23033","article-title":"Overweight and obesity in patients with cystic fibrosis: a center-based analysis","volume":"50","author":"Hanna","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"2019041121300782800_B385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.107.1.1","article-title":"Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group","volume":"107","author":"Farrell","year":"2001","journal-title":"Pediatrics"},{"key":"2019041121300782800_B386","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ppul.1950110713","article-title":"Growth evaluation at one year of life in infants with cystic fibrosis diagnosed by neonatal screening","volume":"7","author":"Pederzini","year":"1991","journal-title":"Pediatr Pulmonol Suppl"},{"key":"2019041121300782800_B387","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0022-3476(98)70024-1","article-title":"Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition","volume":"132","author":"Lai","year":"1998","journal-title":"J Pediatr"},{"key":"2019041121300782800_B388","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/archpedi.1984.02140420054017","article-title":"Short stature and pubertal delay in male adolescents with cystic fibrosis. Androgen treatment","volume":"138","author":"Landon","year":"1984","journal-title":"Am J Dis Child"},{"key":"2019041121300782800_B389","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/adc.75.3.191","article-title":"Head growth in cystic fibrosis following early diagnosis by neonatal screening","volume":"75","author":"Ghosal","year":"1996","journal-title":"Arch Dis Child"},{"key":"2019041121300782800_B390","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/adc.72.2.150","article-title":"Disproportionate head growth retardation in cystic fibrosis","volume":"72","author":"Ghosal","year":"1995","journal-title":"Arch Dis Child"},{"key":"2019041121300782800_B391","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jpeds.2005.04.031","article-title":"Gestational and neonatal characteristics of children with cystic fibrosis: a cohort study","volume":"147","author":"Festini","year":"2005","journal-title":"J Pediatr"},{"key":"2019041121300782800_B392","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1569-1993(03)00023-7","article-title":"Growth in prepubertal children with cystic fibrosis, homozygous for the Delta F508 mutation","volume":"2","author":"Keller","year":"2003","journal-title":"J Cyst Fibros"},{"key":"2019041121300782800_B393","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ppul.23042","article-title":"Glucose tolerance affects pubertal growth and final height of children with cystic fibrosis","volume":"50","author":"Bizzarri","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"2019041121300782800_B394","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.clnu.2012.08.017","article-title":"Stunting is an independent predictor of mortality in patients with cystic fibrosis","volume":"32","author":"Vieni","year":"2013","journal-title":"Clin Nutr"},{"key":"2019041121300782800_B395","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2478\/v10042-010-0051-x","article-title":"Age of menarche in girls with cystic fibrosis","volume":"48","author":"Um\u0142awska","year":"2010","journal-title":"Folia Histochemica Et Cytobiologica"},{"key":"2019041121300782800_B396","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.99.1.29","article-title":"Delayed puberty in girls with cystic fibrosis despite good clinical status","volume":"99","author":"Johannesson","year":"1997","journal-title":"Pediatrics"},{"key":"2019041121300782800_B397","first-page":"253","article-title":"Short stature and pubertal delay in cystic fibrosis","volume":"14","author":"Landon","year":"1987","journal-title":"Pediatrician"},{"key":"2019041121300782800_B398","first-page":"186","article-title":"Psychological development as related to puberty, body height and severity of illness in adolescents with cystic fibrosis","volume":"27","author":"Sinnema","year":"1991","journal-title":"Israel J Med Sci"},{"key":"2019041121300782800_B399","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/ajcn\/69.3.531","article-title":"Comparison of growth status of patients with cystic fibrosis between the United States and Canada","volume":"69","author":"Lai","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"2019041121300782800_B400","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1651-2227.2003.tb02571.x","article-title":"Pubertal growth and development in cystic fibrosis: a retrospective review","volume":"92","author":"Aswani","year":"2003","journal-title":"Acta Paediatr"},{"key":"2019041121300782800_B401","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ppul.21001","article-title":"Growth and long-term lung function in cystic fibrosis: a longitudinal study of patients diagnosed by neonatal screening","volume":"44","author":"Assael","year":"2009","journal-title":"Pediatr Pulmonol"},{"key":"2019041121300782800_B402","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1136\/archdischild-2011-300449","article-title":"Improved survival in cystic fibrosis patients diagnosed by newborn screening compared to a historical cohort from the same centre","volume":"96","author":"Dijk","year":"2011","journal-title":"Arch Dis Child"},{"key":"2019041121300782800_B403","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/adc.77.6.497","article-title":"Height and weight in cystic fibrosis: a cross sectional study. UK Cystic Fibrosis Survey Management Committee","volume":"77","author":"Morison","year":"1997","journal-title":"Arch Dis Child"},{"key":"2019041121300782800_B404","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jcf.2012.08.003","article-title":"Growth retardation and reduced growth hormone secretion in cystic fibrosis. Clinical observations from three CF centers","volume":"12","author":"Ciro","year":"2013","journal-title":"J Cyst Fibros"},{"key":"2019041121300782800_B405","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1651-2227.2001.tb02447.x","article-title":"Insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in cystic fibrosis: a positive effect of antibiotic therapy and hyperalimentation","volume":"90","author":"Lebl","year":"2001","journal-title":"Acta Paediatr"},{"key":"2019041121300782800_B406","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1442-200x.2004.01925.x","article-title":"Relation between serum insulin-like growth factor-I and insulin-like growth factor-binding protein-3 levels, clinical status, and growth parameters in prepubertal cystic fibrosis patients","volume":"46","author":"Ozen","year":"2004","journal-title":"Pediatr Int"},{"key":"2019041121300782800_B407","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/adc.72.6.494","article-title":"Diminished concentrations of insulin-like growth factor I in cystic fibrosis","volume":"72","author":"Laursen","year":"1995","journal-title":"Arch Dis Child"},{"key":"2019041121300782800_B408","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1515\/JPEM.2009.22.5.417","article-title":"Insulin-like growth factor-I levels predict weight, height and protein catabolism in children and adolescents with cystic fibrosis","volume":"22","author":"Switzer","year":"2009","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2019041121300782800_B409","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/adc.88.11.956","article-title":"Insulin-like growth factor I correlates with lean body mass in cystic fibrosis patients","volume":"88","author":"Sermet-Gaudelus","year":"2003","journal-title":"Arch Dis Child"},{"key":"2019041121300782800_B410","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ppul.22822","article-title":"Serum insulin-like growth factor-1 (IGF-1) during CF pulmonary exacerbation: trends and biomarker correlations","volume":"49","author":"Gifford","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"2019041121300782800_B411","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000315902","article-title":"Effect of testosterone therapy for delayed growth and puberty in boys with inflammatory bowel disease","volume":"75","author":"Mason","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"2019041121300782800_B412","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1046\/j.1365-2265.1999.00858.x","article-title":"The relationship between insulin, IGF-I and weight gain in cystic fibrosis","volume":"51","author":"Taylor","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121300782800_B413","doi-asserted-by":"crossref","first-page":"18000","DOI":"10.3390\/ijms151018000","article-title":"FOXO1 content is reduced in cystic fibrosis and increases with IGF-I treatment","volume":"15","author":"Smerieri","year":"2014","journal-title":"Int J Mol Sci"},{"key":"2019041121300782800_B414","doi-asserted-by":"crossref","first-page":"e1211","DOI":"10.1542\/peds.2010-2007","article-title":"Recombinant human growth hormone in the treatment of patients with cystic fibrosis","volume":"126","author":"Phung","year":"2010","journal-title":"Pediatrics"},{"key":"2019041121300782800_B415","first-page":"CD008901","article-title":"Recombinant growth hormone therapy for cystic fibrosis in children and young adults","volume":"6","author":"Thaker","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2019041121300782800_B416","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2265.2005.02259.x","article-title":"A retrospective study of growth hormone use in adolescents with cystic fibrosis","volume":"62","author":"Hardin","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121300782800_B417","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/S0022-3476(97)70015-5","article-title":"Effects of growth hormone treatment in children with cystic fibrosis: The National Cooperative Growth Study experience","volume":"131","author":"Hardin","year":"1997","journal-title":"J Pediatr"},{"key":"2019041121300782800_B418","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1055\/s-2007-978949","article-title":"Growth hormone improves weight velocity and height velocity in prepubertal children with cystic fibrosis","volume":"30","author":"Hardin","year":"1998","journal-title":"Horm Metab Res"},{"key":"2019041121300782800_B419","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/07315724.1998.10718788","article-title":"Anabolic effects of growth hormone treatment in young children with cystic fibrosis","volume":"17","author":"Alemzadeh","year":"1998","journal-title":"J Am Coll Nutr"},{"key":"2019041121300782800_B420","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/(SICI)1099-0496(199608)22:2<90::AID-PPUL2>3.0.CO;2-N","article-title":"Anabolic effect of biosynthetic growth hormone in cystic fibrosis patients","volume":"22","author":"Huseman","year":"1996","journal-title":"Pediatr Pulmonol"},{"key":"2019041121300782800_B421","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-277X.1995.tb00311.x","article-title":"Growth hormone as a nutritional adjunct in cystic fibrosis: results of a pilot study","volume":"8","author":"Sackey","year":"1995","journal-title":"J Hum Nutr Diet"},{"key":"2019041121300782800_B422","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ppul.21546","article-title":"A multi-center controlled trial of growth hormone treatment in children with cystic fibrosis","volume":"47","author":"Stalvey","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"2019041121300782800_B423","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1067\/mpd.2001.117578","article-title":"Growth hormone improves clinical status in prepubertal children with cystic fibrosis: results of a randomized controlled trial","volume":"139","author":"Hardin","year":"2001","journal-title":"J Pediatr"},{"key":"2019041121300782800_B424","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1210\/jc.2006-1101","article-title":"Growth hormone treatment improves growth and clinical status in prepubertal children with cystic fibrosis: results of a multicenter randomized controlled trial","volume":"91","author":"Hardin","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121300782800_B425","doi-asserted-by":"crossref","first-page":"e1230","DOI":"10.1542\/peds.2006-2783","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis","volume":"119","author":"Schnabel","year":"2007","journal-title":"Pediatrics"},{"key":"2019041121300782800_B426","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1249\/00005768-200204000-00001","article-title":"Effect of growth hormone on exercise tolerance in children with cystic fibrosis","volume":"34","author":"H\u00fctler","year":"2002","journal-title":"Med Sci Sports Exerc"},{"key":"2019041121300782800_B427","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jpeds.2004.10.037","article-title":"Growth hormone treatment enhances nutrition and growth in children with cystic fibrosis receiving enteral nutrition","volume":"146","author":"Hardin","year":"2005","journal-title":"J Pediatr"},{"key":"2019041121300782800_B428","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4049\/jimmunol.1300221","article-title":"Low levels of insulin-like growth factor-1 contribute to alveolar macrophage dysfunction in cystic fibrosis","volume":"191","author":"Bessich","year":"2013","journal-title":"J Immunol"},{"key":"2019041121300782800_B429","doi-asserted-by":"crossref","first-page":"e59992","DOI":"10.1371\/journal.pone.0059992","article-title":"Insulin-like growth factor 1 (IGF-1) enhances the protein expression of CFTR","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS One"},{"key":"2019041121300782800_B430","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/adc.88.12.1078","article-title":"Prospective randomised treatment with recombinant human growth hormone in cystic fibrosis","volume":"88","author":"Schibler","year":"2003","journal-title":"Arch Dis Child"},{"key":"2019041121300782800_B431","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1542\/peds.110.5.889","article-title":"Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study","volume":"110","author":"Gravholt","year":"2002","journal-title":"Pediatrics"},{"key":"2019041121300782800_B432","first-page":"769","article-title":"Carbohydrate metabolism during long-term growth hormone (GH) treatment and after discontinuation of GH treatment in girls with Turner syndrome participating in a randomized dose-response study. Dutch Advisory Group on Growth Hormone","volume":"85","author":"Sas","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121300782800_B433","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000319709","article-title":"Effects on growth and metabolism of growth hormone treatment for 3 years in 36 children with Prader-Willi syndrome","volume":"75","author":"Colmenares","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"2019041121300782800_B434","first-page":"83","article-title":"Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader-Willi syndrome","volume":"68","author":"Crin\u00f2","year":"2007","journal-title":"Horm Res"},{"key":"2019041121300782800_B435","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000329729","article-title":"Metabolic impact of growth hormone treatment in short children born small for gestational age","volume":"76","author":"Lebl","year":"2011","journal-title":"Horm Res Paediatr"},{"issue":"suppl 3","key":"2019041121300782800_B436","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000330159","article-title":"Safety of growth hormone treatment of children with idiopathic short stature: the US experience","volume":"76","author":"Allen","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"2019041121300782800_B437","doi-asserted-by":"crossref","first-page":"E1025","DOI":"10.1210\/jc.2010-3023","article-title":"Prevalence and incidence of diabetes mellitus in GH-treated children and adolescents: analysis from the GeNeSIS observational research program","volume":"96","author":"Child","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121300782800_B438","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1210\/jcem.82.12.4422","article-title":"Dose-dependent effects of recombinant human interleukin-6 on glucose regulation","volume":"82","author":"Tsigos","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121300782800_B439","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diab.40.1.141","article-title":"Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans","volume":"40","author":"Horber","year":"1991","journal-title":"Diabetes"},{"key":"2019041121300782800_B440","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1159\/000313589","article-title":"Moderate deterioration in glucose tolerance during high-dose growth hormone therapy in glucocorticoid-treated patients with juvenile idiopathic arthritis","volume":"73","author":"Bismuth","year":"2010","journal-title":"Horm Res Paediatr"},{"key":"2019041121300782800_B441","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/edpract-2011-301426","article-title":"Assessment of childhood obesity in secondary care: OSCA consensus statement","volume":"97","author":"Viner","year":"2012","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"2019041121300782800_B442","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2337\/dc08-1925","article-title":"Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis: a prospective cohort study","volume":"32","author":"O'Riordan","year":"2009","journal-title":"Diabetes Care"},{"key":"2019041121300782800_B443","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1210\/jc.2009-0178","article-title":"Long-term safety of recombinant human growth hormone in children","volume":"95","author":"Bell","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121300782800_B444","first-page":"458","article-title":"Bone diseases in children receiving growth hormone","volume":"69","author":"Smida","year":"2003","journal-title":"Acta Orthop Belg"},{"issue":"suppl 1","key":"2019041121300782800_B445","first-page":"68","article-title":"Safety and efficacy of growth hormone therapy in childhood","volume":"2","author":"Bowlby","year":"2004","journal-title":"Pediatr Endocrinol Rev"},{"key":"2019041121300782800_B446","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.2106\/00004623-197456080-00026","article-title":"Slipped upper femoral epiphysis following treatment with human growth hormone","volume":"56","author":"Fidler","year":"1974","journal-title":"J Bone Joint Surg Am"},{"key":"2019041121300782800_B447","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/pbc.24667","article-title":"Childhood cancer survivors exposed to total body irradiation are at significant risk for slipped capital femoral epiphysis during recombinant growth hormone therapy","volume":"60","author":"Mostoufi-Moab","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"2019041121300782800_B448","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1007\/s00167-010-1370-3","article-title":"Human growth hormone and the development of osteochondritis dissecans lesions","volume":"19","author":"Hussain","year":"2011","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"2019041121300782800_B449","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0016-5085(88)90411-8","article-title":"Collagen content and types in the intestinal strictures of Crohn's disease","volume":"94","author":"Graham","year":"1988","journal-title":"Gastroenterology"},{"key":"2019041121300782800_B450","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0016-5085(92)90087-F","article-title":"Cellular localization of procollagen gene transcripts in inflammatory bowel diseases","volume":"102","author":"Matthes","year":"1992","journal-title":"Gastroenterology"},{"key":"2019041121300782800_B451","doi-asserted-by":"crossref","first-page":"G342","DOI":"10.1152\/ajpgi.00413.2004","article-title":"Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells","volume":"289","author":"Fruchtman","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2019041121300782800_B452","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1053\/j.gastro.2005.05.019","article-title":"Growth hormone reduces the severity of fibrosis associated with chronic intestinal inflammation","volume":"129","author":"Theiss","year":"2005","journal-title":"Gastroenterology"},{"key":"2019041121300782800_B453","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1210\/jc.2006-0656","article-title":"Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor","volume":"91","author":"Ergun-Longmire","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121300782800_B454","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1210\/jcem.87.7.8606","article-title":"Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study","volume":"87","author":"Sklar","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121300782800_B455","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1210\/jc.2011-0112","article-title":"Long-term safety of growth hormone replacement after CNS irradiation","volume":"96","author":"Mackenzie","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121300782800_B456","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/art.34348","article-title":"Rates of malignancy associated with juvenile idiopathic arthritis and its treatment","volume":"64","author":"Beukelman","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2019041121300782800_B457","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/rheumatology\/keq361","article-title":"Report on malignancies in the German juvenile idiopathic arthritis registry","volume":"50","author":"Horneff","year":"2011","journal-title":"Rheumatology"},{"key":"2019041121300782800_B458","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/acr.21709","article-title":"Risk of malignancy in children with juvenile idiopathic arthritis not treated with biologic agents","volume":"64","author":"Nordstrom","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2019041121300782800_B459","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1053\/j.gastro.2012.04.054","article-title":"Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010","volume":"143","author":"Herrinton","year":"2012","journal-title":"Gastroenterology"},{"key":"2019041121300782800_B460","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.gastro.2012.05.004","article-title":"Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease","volume":"143","author":"Long","year":"2012","journal-title":"Gastroenterology"},{"key":"2019041121300782800_B461","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11102-013-0501-5","article-title":"Increased thyroid cancer risk in acromegaly","volume":"17","author":"Dagdelen","year":"2014","journal-title":"Pituitary"},{"key":"2019041121300782800_B462","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s11102-010-0224-9","article-title":"Thyroid cancer is the most common cancer associated with acromegaly","volume":"13","author":"Gullu","year":"2010","journal-title":"Pituitary"},{"key":"2019041121300782800_B463","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.3748\/wjg.14.3484","article-title":"Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis","volume":"14","author":"Rokkas","year":"2008","journal-title":"World J Gastroenterol"},{"key":"2019041121300782800_B464","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1530\/EJE-10-0859","article-title":"Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies","volume":"164","author":"Steuerman","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2019041121300782800_B465","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.cgh.2007.12.017","article-title":"Anti-aging therapy with human growth hormone associated with metastatic colon cancer in a patient with Crohn's colitis","volume":"6","author":"Melmed","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2019041121300782800_B466","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1053\/j.gastro.2004.05.016","article-title":"Suppressor of cytokine signaling-2: a growth hormone-inducible inhibitor of intestinal epithelial cell proliferation","volume":"127","author":"Miller","year":"2004","journal-title":"Gastroenterology"},{"key":"2019041121300782800_B467","doi-asserted-by":"crossref","first-page":"G472","DOI":"10.1152\/ajpgi.00218.2005","article-title":"Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo","volume":"291","author":"Michaylira","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2019041121300782800_B468","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1530\/JOE-14-0292","article-title":"Direct stimulation of bone mass by increased GH signalling in the osteoblasts of Socs2\u2212\/\u2212 mice","volume":"223","author":"Dobie","year":"2014","journal-title":"J Endocrinol"},{"key":"2019041121300782800_B469","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000085760","article-title":"IGFs and IGFBPs in GH insensitivity","volume":"9","author":"Savage","year":"2005","journal-title":"Endocr Dev"},{"key":"2019041121300782800_B470","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/eje.0.1500635","article-title":"Primary GH insensitivity' (Laron syndrome) caused by a novel 4 kb deletion encompassing exon 5 of the GH receptor gene: effect of intermittent long-term treatment with recombinant human IGF-I","volume":"150","author":"Besson","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"2019041121300782800_B471","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1210\/jc.2006-1610","article-title":"Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity","volume":"92","author":"Chernausek","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl 1","key":"2019041121300782800_B472","first-page":"154","article-title":"Diagnosis and management of primary insulin-like growth factor-I deficiency: current perspectives and clinical update","volume":"7","author":"Backeljauw","year":"2010","journal-title":"Pediatr Endocrinol Rev"},{"key":"2019041121300782800_B473","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1210\/jc.2009-0570","article-title":"Recombinant insulin-like growth factor (IGF)-I treatment in short children with low IGF-I levels: first-year results from a randomized clinical trial","volume":"95","author":"Midyett","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121300782800_B474","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrendo.2013.71","article-title":"Treatment of children and adolescents with idiopathic short stature","volume":"9","author":"Ranke","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"2019041121300782800_B475","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/eji.1830260704","article-title":"Mouse \u03b3 \u03b4 TCR+NK1.1+ thymocytes specifically produce interleukin-4, are major histocompatibility complex class I independent, and are developmentally related to \u03b1 \u03b2 TCR+NK1.1+ thymocytes","volume":"26","author":"Vicari","year":"1996","journal-title":"Eur J Immunol"},{"key":"2019041121300782800_B476","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1530\/EJE-14-0419","article-title":"A randomised controlled trial evaluating IGF1 titration in contrast to current GH dosing strategies in children born small for gestational age: the North European Small-for-Gestational-Age Study","volume":"171","author":"Jensen","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"2019041121300782800_B477","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1523-1755.2000.00141.x","article-title":"Growth hormone receptor abundance in tibial growth plates of uremic rats: GH\/IGF-I treatment","volume":"58","author":"Edmondson","year":"2000","journal-title":"Kidney Int"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/37\/1\/62\/8865145\/edrv0062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T14:47:10Z","timestamp":1718290030000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/37\/1\/62\/2354716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,31]]},"references-count":477,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,31]]},"published-print":{"date-parts":[[2016,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2015-1026","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,31]]}}}